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Preventive cancer screenings are essential to early detect cancer and subsequently save 
lives. However, out-of-pocket expenditures for cancer screening services deter individuals from 
obtaining them. In an effort to improve the utilization of cancer screening, the Affordable Care 
Act (ACA) implemented a cost-sharing elimination provision that removes all forms of cost-
sharing including copayments, co-insurance and deductibles from certain preventive care services 
that are recommended by widely known scientific figures such as the United States Preventive 
Services Task Force (USPSTF). 
This study evaluated the impact of the ACA cost-sharing elimination provision for 
preventive care services from 2008 through 2016 using a differences in differences (DID) 
approach. The approach compared utilization changes overtime between the insured (treatment 
group) and the uninsured (control group). This study investigated the impact of the ACA cost-
sharing elimination provision on the utilization of three cancer prevention screenings, particularly, 
breast, cervical, and colorectal cancer screenings, among individuals who were privately insured 
and/or Medicare-insured, before and after the cost-sharing elimination provision enactment. This 
provision became effective for private health insurance plans, in 2010, and for Medicare, in 2011. 
A focus of this dissertation was to examine the influence of socio-economic and socio-
 viii 
demographic factors on utilization changes. These factors were determined with the guidance of 
the Andersen Healthcare Utilization model which states that the usage of health services is 
determined by the three dynamics: predisposing, enabling, and need factors.   
This study utilized data from the national Medical Expenditure Panel Survey (MEPS). The 
MEPS is a nationally representative survey of non-institutionalized United States (US) individuals 
and families. The results of this dissertation expand the current knowledge of the impact of the 
ACA cost-sharing elimination provision on increasing utilization of three cancer screenings and 
provides policy makers and health professionals with much needed information for decision-
making.  
The results of this study demonstrate that the ACA cost-sharing elimination provision did 
not have an impact on the utilization of the examined cancer screening services including 
mammography, Pap smear, FOBT, colonoscopy and sigmoidoscopy. However, there were some 
predisposing, enabling, and need factors that showed a significant effect on utilization rates, 
suggesting that future research is necessary to understand and evaluate the impact of cost-sharing 
on access to cancer preventive care services. 
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INTRODUCTION 
Increasing the uptake of preventive care screening services for breast, cervical, and 
colorectal (CRC) cancer is critical for improving the health of the population because of their high 
potential for decreasing the burden of cancer in the United States (US) (Maciosek et al, 2009). 
Despite the significant efforts that have been made to increase cancer screenings, screening rates 
for breast, cervical, and CRC cancer remain suboptimal with the current rates disappointingly low. 
The excessive economic costs of cancer create a burden on individuals and the overall society. In 
2015, the Agency for Healthcare Research and Quality (AHRQ) estimated that the total of all 
health care costs for cancer in the nation were $80.2 billion. Similarly, a study estimating the 
national total cost of cancer care from 2010 to 2020 projected costs to increase to $157.77 billion 
in 2020 as a result of an aging population; assuming that incidence, survival, and costs for main 
cancer sites would remain constant (Mariotto et al, 2011). In addition to costs, cancer is a deadly 
disease, particularly when not identified early. In fact, cancer is the second most common cause of 
death in the US after heart disease. This year, about 606,880 Americans will die from cancer, 
which is more than 1,670 people a day (American Cancer Society, 2019; Siegel et al, 2019). Given 
the high death rate expected from cancer, the role of policy has become fundamental in 
implementing policies that promote cancer screenings. One major attempt was the implementation 
of the Affordable Care Act (ACA) that included a variety of provision aiming to increase cancer 
screening and eventually an early cancer diagnosis and treatment that can save many lives.  
The ACA cost-sharing elimination provision for preventive services is one of the 
provisions that aims to increase screening rates through the elimination of financial barriers that 
are presumed to deter individuals from obtaining the screenings. These financial barriers were 
costs incurred by the individuals in various forms including co-payments, deductibles, and 
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coinsurance. This provision became effective for private health insurance plans, in 2010, and for 
Medicare in 2011. The impact of the ACA cost-sharing elimination policy provision can be 
assessed by evaluating the receipt of breast, cervical, and CRC cancer screenings among privately 
and Medicare insured adults pre-and post ACA implementation after controlling for certain socio-
demographic and socioeconomic factors.  
Although previous studies have established that cost-sharing elimination could potentially 
increase preventive health services utilization, many of these studies have not investigated socio-
demographic and socioeconomic differences, or time trends in preventive services use (Han et al, 
2015). Additionally, there are only a few studies which evaluated the effects of cost-sharing on 
use of cancer preventive services in national samples (Rezayatmand et al, 2013) and most of the 
studies examined only a short period after the ACA because of the unavailability of data. This 
dissertation expands the body of knowledge by examining a variety of socio-demographic and 
socioeconomic factors that could have a significant impact on the utilization of cancer screenings 
particularly, breast, cervical, and CRC cancer screenings, utilizing national data form 2008 through 
2016.  The study sought to demonstrate the effect of the ACA cost-sharing elimination provision 
on cancer screenings rates and disparities among different groups in an effort to provide 
information to policy makers and health professionals on the outcome of the cost-sharing 
elimination provision. Guided by  the well-established Andersen’s Behavioral Model of Health 
Services Use (BM) with supporting evidence from the literature, this study identified socio-
demographic and socioeconomic factors associated with screening. If the evidence indicates better 
health coverage and enhanced access does not lead to the optimal utilization of preventive care 
services, exploration of reasons for suboptimal cancer screening rates are explored. 
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BACKGROUND AND LITERATURE REVIEW 
Preventive health services are vital because they enable early detection of diseases before 
the development of clinical symptoms. Lower utilization of preventive services is a major public 
health concern especially with the growing number of chronic diseases that are very costly to 
manage. On a national level, Americans use only half of the recommended level of preventive care 
services (Centers for Disease Control and Prevention (CDC), 2017) attributing to the leading 
causes of death, with the first cause of death being the diseases of the heart followed by cancer 
(Table 1). In fact, heart diseases and malignant neoplasms are responsible for about half of total 
deaths in the nation (CDC, 2015). In total, chronic conditions are responsible for 7 out of 10 deaths 
among Americans yearly and account for approximately 75% of the total nation’s health spending. 
By 2030, it is estimated that more than 81 million Americans will have at least one chronic illness 
(Wu and Green, 2000) with projected costs related to their rising from $1.3 trillion in 2003 to $4.2 
trillion by 2023 (Bodenheimer and Bennett, 2009). The leading causes of deaths in the U.S. in 
2015 are listed in Table 1. 
Table 1. Leading Causes of Death and Number of Deaths: United States, 2015 
Cause of Death Deaths 
All causes 2,712,630 
Diseases of heart 633,842 (23.4%) 
Malignant neoplasms 595,930 (21.9%) 
Chronic lower respiratory diseases 155,041 (5.7%) 
Unintentional injuries 146,571 (5.4%) 
Cardiovascular diseases 140,323 (5.2%) 
Alzheimer’s disease 110,561 (4.1%) 
Diabetes Mellitus 79,535 (2.9%) 
Influenza and pneumonia 57,062 (2.1%) 
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Nephritis, nephrotic syndrome, and nephrosis 49,959 (1.8%) 
Suicide 44,193 (1.6%) 
  Source: Centers for Disease Control and Prevention https://www.cdc.gov/nchs/data/hus/hus16.pdf#019 
 
Chronic conditions can be largely preventable through appropriate preventive services and 
screenings. A study that examined the health benefits of using nine recommended clinical 
preventive services, including mammography, colonoscopy, and the pap smear test, reported that 
these screening could prevent the annual death of approximately 25,000 to 40,000 Americans 
under 65 years and 50,000 to 100,000 Americans under the age of 80 years (Farley et al, 2010). 
Cancer screening services had a lower probability to save lives, with colonoscopy having the 
probability to prevent the highest number of deaths, which is 1900 deaths to be avoided each year 
for a 10% increase in screenings. Preventive care services could lead to major savings in health 
care spending. A study conducted to measure the medical costs and life savings of a package of 
twenty evidence-based services including breast, cervical, and CRC cancer screenings showed that 
improving the utilization of preventive services to 90% can save the healthcare system $3.7 billion 
and 2 million lives annually (Maciosek et al, 2010). It is evident that with increased utilization of 
effective preventive services including cancer screenings, many lives would be prevented and 
immense costs would be saved.  
The Affordable Care Act Cost-Sharing Elimination Provision     
Before the implementation of the ACA, many insurance plans required cost-sharing for 
preventive services. Insured individuals were responsible for various forms of cost-sharing, 
including copayments, co-insurance, and meeting plan deductibles; these charges were often 
substantial out-of-pocket expenses for some screening services. Medicare beneficiaries who did 
not have supplemental insurance were required to pay 20% of the cost of many preventive services, 
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whereas Medicare beneficiaries with supplemental plans (Advantage plans) were responsible to 
pay more than this amount (Pyenson et al, 2014). For mammogram, the average out-of-pocket 
charge for women with any type of insurance was approximately $33, which was 14.1% of the 
total charge ($266) (Lemasters and Sambamoorthi, 2008). Although a $33-dollar charge seems to 
be trivial, research has shown that an expense exceeding $10 can deter underserved women from 
obtaining screening services, specifically a mammogram (McAlearney et al, 2007). Prior to the 
ACA, women who were privately insured or without insurance were found to be more likely to 
pay a part or the total cost of a mammogram compared to women who had federal or state insurance 
such as Medicare and/or Medicaid (Pagan et al, 2008). Out-of-pocket expenses drastically vary 
among different types of cancer screenings. For the pap smear test, the average out-of-pocket 
charge for insured individuals ranged from $3 to $11 before the ACA, which was the lowest 
amount among the five cancer screenings examined in this study (Goodwin and Anderson, 2012). 
Colonoscopy, which is the most common type of CRC cancer screening test, was more expensive 
than both the FOBT test and sigmoidoscopy. In 2010, the average cost sharing requirement for 
colonoscopy was approximately $334 for privately insured individuals and $275 for Medicare 
insured individuals. These cost requirements were a small percent of the total screenings costs of 
$2146 (15.6%) and $1071 (25.7%), respectively (Pyenson et al, 2014). On the other hand, the out-
of-pocket expenses before the ACA ranged from $12 to $23 for a the FOBT test and $55-$171 for 
sigmoidoscopy, which were considerably smaller amounts (Goodwin and Anderson, 2012). 
A growing body of literature has shown that out-of-pocket expenditures are a major 
financial barrier in utilizing preventive care services (Cooper et al, 2016; Rezayatmand et al, 2013; 
Trivedi et al, 2008; Koh and Sebelius, 2010; Goodwin and Anderson, 2012). Accordingly, an 
emerging body of research has shown that eliminating cost-sharing for preventive services may be 
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essential to increase their utilization to recommended levels (Solanki et al, 2000). Researchers who 
estimated the direct and indirect effects of cost-sharing on pap smearing and mammography found 
that it negatively impacted the receipt of preventive care, suggesting that cost-sharing elimination 
increases preventive care service utilization (Solanki et al, 2000).   
Past legislation has had similar goals as the ACA, aiming to make health care more 
accessible and more affordable. Many of these reforms were successful in improving preventive 
care utilization. An important example comes from the state of Massachusetts that expanded to a 
near-universal health insurance coverage in 2006. A study comparing the effects of the 
Massachusetts reform on mammograms and pap smear tests between 2002 and 2010 found a 
significant increase in their utilization, especially among low-income women (Sabik and Bradley, 
2016). Goodwin and Anderson found that after the 1997 elimination of cost-sharing legislation, 
which provided a deductible waiver for Medicare beneficiaries, pap smear tests and mammograms 
significantly increased in their utilization (Goodwin and Anderson, 2012). Another study 
examining the effect of a provision under the 2003 Medicare Prescription Drug, Improvement, and 
Modernization Act, that expanded the coverage of preventive services, reported an increase in 
utilization of mammograms and pap smear tests, especially among individuals with lower 
deductible plans (Meeker et al., 2011). The success from previous reforms indicate that there is a 
high potential for the ACA to reach its intended outcomes, especially in cancer preventive care, 
over a long period of time. 
Research has consistently shown that cost-sharing in all forms creates a financial barrier 
on individuals and reduces the utilization of preventive services and (Rubin and Mendelson, 1995). 
Therefore, in an effort to increase access and control costs, in 2010, the ACA mandated that private 
health plans should cover forty-five specific recommended preventive services and eliminate all 
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forms of cost-sharing such as copayments, deductibles and co-insurance. Since out-of-pockets 
payments are identified as a barrier to utilize preventive care services among both insured and 
uninsured individuals, they were eliminated under this provision to enhance access to preventive 
services, including breast, cervical and CRC cancer screenings. 
The screening guidelines and recommendations for the recommended preventive services 
come from public medical and scientific organizations including the U.S. Preventive Services Task 
Force (USPSTF) and the Advisory Committee on Immunization Practices (ACIP). The USPSTF 
is volunteer panel of independent national experts who develops specific recommendations for 
clinical preventive services to the health care system in the US based on the most up-to-date 
scientific evidence. The USPSTF provides primary and secondary prevention recommendations 
that aim to monitor clinical and preventive care and are adopted by several federal and private 
groups as they are widely considered the best resource for preventive services management (Moyer 
et al., 2011; USPSTF, 2013). The USPSTF assigns a letter grade for each recommendation (an A, 
B, C, or D grade or an I statement; describe below) based on the strength of the scientific evidence 
supporting its benefits. The grade assigned to a service does not relate to the cost of that service. 
Along with the USPSTF recommendations, the ACIP provides recommendations that perform as 
a standard to guide safe use of vaccines among children and adults. The ACIP is a group of medical 
and public health experts who develops evidence based recommendations and standards of 
vaccinations among the US population.  
Precisely, the ACA cost-sharing elimination provision mandates that health coverage plans 
eliminate cost-sharing of all forms for preventive services recommended by the USPSTF that have 
a rating of A or B (Shearer, 2010). These are new requirements specified by the ACA, as formerly 
private coverage plans were not required to comprehensively pay for an authorized group of 
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preventive services. For more information about the grades definitions from the USPTSF, refer to 
Table 2. 
 
The ACA cost-sharing elimination requirement was extended to all new and renewed 
private health plans after September 23, 2010. Private health plans must be individual plans, small 
Table 2. USPSTF Ratings: What the Grades Mean and Suggestions for Practice 
Grade Definition Suggestions for Practice 
A The USPSTF recommends the service. 
There is high certainty that the net benefit 
is substantial. 
Offer or provide this service. 
B The USPSTF recommends the service. 
There is high certainty that the net benefit 
is moderate or there is moderate certainty 
that the net benefit is moderate to 
substantial. 
Offer or provide this service. 
C Clinicians may provide this service to 
selected patients depending on individual 
circumstances. However, for most 
individuals without signs or symptoms 
there is likely to be only a small benefit 
from this service. 
Offer or provide this service only if 
other considerations support the 
offering or providing the service in an 
individual patient. 
D The USPSTF recommends against the 
service. There is moderate or high 
certainty that the service has no net 
benefit or that the harms outweigh the 
benefits. 
Discourage the use of this service. 
I 
Statement 
The USPSTF concludes that the current 
evidence is insufficient to assess the 
balance of benefits and harms of the 
service. Evidence is lacking, of poor 
quality, or conflicting, and the balance of 
benefits and harms cannot be determined. 
Read the clinical considerations 
section of USPSTF Recommendation 
Statement. If the service is offered, 
patients should understand the 
uncertainty about the balance of 
benefits and harms. 
Source: U.S. Preventive Services Task Force Ratings. U.S. Preventive Services Task Force. December 2013. 
https://www.uspreventiveservicestaskforce.org/Page/Name/us-preventive-services-task-force-ratings 
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and large business plans, and self-insured plans. However, the provision did not apply to 
grandfathered plans, which are private coverage plans that were created or acquired before March 
23, 2010. Cost-sharing was later eliminated for Medicare beneficiaries on January 1, 2011 (Koh 
and Sebelius, 2010) (Centers for Medicare & Medicaid Services). The aim for eliminating these 
costs was to improve utilization of preventive services by eliminating cost barriers that inhibit 
individuals from obtaining preventive services and thus increase access to eventually improve 
population health.  For more information about the specifics of this provision for private coverage 
plans, refer to the Table 3 below, which was adapted from the U.S. Department of Health and 
Human Services (Health Policy Brief, Health Affairs, 2010). 
 
Table 3. Preventive Services Required of New Group & Individual Health Plans Without 
Cost Sharing 
Evidence-based preventive services 
 
Preventive services recommended by the 
U.S. Preventive Services Task Force based 
on the strength of the scientific evidence 
documenting their benefits. Includes breast 
and colon cancer screenings, screening for 
vitamin deficiencies during pregnancy, 
diabetes, high cholesterol, high blood 
pressure, and tobacco cessation counseling 
 
Routine vaccinations 
 
Sets of standard vaccines recommended by 
the Advisory Committee on Immunization 
Practices, ranging from routine childhood 
immunizations to periodic tetanus shots for 
adults 
 
Preventive services for children  
 
Preventive services recommended under the 
Bright Futures guidelines developed by the 
Health Resources and Services 
Administration and the American Academy 
of Pediatrics for children from birth to age 
21. Includes regular pediatrician visits, vision 
and hearing screening, developmental 
assessments, immunizations, and screening 
and counseling to address obesity 
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Preventive services for women 
 
Will also include services recommended 
under new guidelines expected to be issued 
by August 2011, in addition to services 
recommended by the Preventive Services 
Task Force 
 
Source: Cassidy, Amanda. “Health Policy Brief: Preventive Services Without Cost Sharing.” Robert Wood 
Johnson Foundation Health Policy Brief Series. Health Affairs, December 28, 2010.  
 
  
The Impact of the ACA on Preventive Care Services Utilization 
Shortly after the implementation of the ACA cost-sharing elimination provision for 
preventive services, many researchers examined the impact on the prevalence of the preventive 
services that were covered. Some researchers examined a package of these services, while some 
only examined specific illness related screenings, such as cancer screening tests and cardiovascular 
related screening tests. Many studies found significant increases in the utilization of preventive 
services indicating a positive effect of the provision. A study conducted to examine the effects of 
the ACA provision on the receipt of preventive care among young adults between 2009 and 2011 
found a significant increase in the receipt of preventive services, particularly in routine 
examination, blood pressure screening, cholesterol screening and the annual dental visit (Lau et 
al, 2014). Using a time series data method, an analysis of mammography utilization that examined 
patient level data from a large community-based health system from 2008 to 2012 showed that 
mammography usage increased significantly among women who were form the recommended age 
group of 50 to 74 (Nelson, 2015). A more recent study that was conducted to measure the impact 
of the ACA elimination of out-of-pocket payments on mammography and colonoscopy among 
Medicare beneficiaries between 2009/2010 and 2011/2012 found a significant increase in 
mammography utilization but not in colonoscopy (Cooper et al, 2016). Using the National Health 
Interview Survey data, an analysis of mammography utilization between 2010 and 2013 among 
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Medicare beneficiaries showed a modest increase (Sabatino, et al, 2016). A following study 
examining mammography rates between 2007 and 2012 among Medicare women, who were part 
of a large Medicare advantage health plan, found a slight increase in mammography utilization 
among women with no previous screenings (Jena et al, 2017). The previous studies suggest 
positive gains from the ACA cost-sharing elimination provision, however, the literature was mixed 
with different observations of the ACA effect.  
There were other studies that found very little impact of the provision on cancer preventive 
screenings, or the impact being more prevalent in specific underprivileged groups including the 
poor and the elderly. For example, Fedewa and colleagues examined the utilization of 
mammography and CRC cancer screenings, (colonoscopy, FOBT, and sigmoidoscopy), between 
2008 and 2013, among privately and Medicare insured individuals. The results showed a 
significant increase in CRC screenings among individuals with low socio-economic status or who 
were older. However, no change was found in the utilization of mammography (Fedewa et al, 
2015). A similar study conducted to evaluate whether the ACA provision has resulted in an 
increased use of CRC cancer screenings found no significant change, however, colonoscopy 
utilization increased among Medicare beneficiaries who were poor and without additional 
Medicare coverage (Richman et al, 2016). Similarly, a study examining colonoscopy utilization 
among Medicare elderly men found a significant increase in utilization of colonoscopy, especially 
among the group of men who were from a lower socio-economic status, on the other hand, there 
was no significant change among elderly women that was explained to be related to other 
behavioral factors (Hamman and Kapinos, 2015). In a pre/post analysis using administrative date 
for Medicare beneficiaries from rural health clinics, increases in CRC cancer screening rates were 
observed (Wan et al, 2015). In the following section, we will discuss the observations of some 
 23 
evidence based research that showed a null or negative impact of the ACA cost-sharing elimination 
provision for preventive care services. 
There were several studies that found no evidence of a positive effect related to the ACA 
provision. Mehta and colleagues examined the impact of the ACA provision on colonoscopy and 
mammography, between 2008 and 2012, among an insured small business population 
(HUMANA) and found no significant change in utilization of both cancer screenings (Mehta et al, 
2015). However, the study concluded that the null findings might be due to the short period after 
the policy implementation, which might have not been enough to allow for the intended results to 
appear (Mehta et al, 2015). Han and colleagues evaluated changes in the utilization of cervical, 
breast, and CRC cancer screenings, between 2009 and 2012 among the privately and Medicare 
insured individuals, and found no change in utilization after controlling for demographic variables, 
confounding variables, and stratification by insurance type (Han et al, 2015). Similarly, a study 
that evaluated the effects of the provision on mammography and CRC cancer screenings among 
Medicare seniors between 2008/2010 and 2012 found no change in utilization even among 
Medicare seniors without supplemental insurance (Jensen et al, 2015). A more recent study 
evaluating the impact of the provision among the privately insured found that changes in the 
utilization of mammograms, pap smears, and CRC cancer screenings were not a result of the ACA 
(Hong et al, 2017). The findings of these studies were not consistent with earlier ones. Studies with 
null findings attributed their results to several factors including the lack of data for long periods of 
time after the ACA (Jensen et al, 2015).  
Utilization of Preventive Services Among Low-income Patients 
 Utilization of health services, in general, is more likely to differ among low-income 
patients as a result to changes in cost-sharing (Baicker and Goldman, 2011). In the RAND Health 
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Insurance Experiment (HIE), which examined the association between demand and behavior, low-
income individuals who were sick had more adverse health outcomes attributable to increased 
cost-sharing. High mortality rates were higher for poor patients with low blood pressure when they 
had higher copayments (Manning et al, 1987). Another study reported that low-income individuals 
made fewer well-informed decisions because of poor communication skills between patients and 
physicians due to a positive correlation between education and income (Reeder and Nelson, 1985). 
In their study of health outcomes by socio-economic status (SES), Goldman and Smith showed 
that individuals with lower socio-economic status tend to have worse health outcomes because 
they are less likely to adhere to the treatment of their chronic conditions (Golden and Smith, 2002).  
From an economics perspective, Chandra and colleagues mentioned three reasons that 
explain why low-income patients have differential effects. Based on their study, low-income 
individuals are more impacted by price because of their restricted budgets, indicating that they are 
expected to obtain less care with the lowest marginal benefit (Chandra et al, 2014). Secondly, low-
income individuals were less likely to evaluate the benefit of their care than individuals with high 
income and, accordingly they are more prone to obtain less high marginal benefit care. Third, it 
was suggested that the effect of cost-sharing could be different for low-income individuals because 
they tend to have more chronic conditions (Chandra et al, 2014). 
           From the existing evidence, it is established that cost-sharing may result in a judicious 
utilization of health care services. Financial requirements tend to reduce the use of valuable care, 
especially for vulnerable groups such as low-income individuals (Chernew et al, 2007). Hence, it 
is imperative to understand the impact of cost-sharing on the use of specific preventive services 
that are identified as methods to improve health, especially amongst low-income individuals, who 
are more prone to adverse health effects because their sensitivity to price that leads lower health 
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care use (Manning et al, 1987). Baicker and Goldman suggested that there is little evidence that 
poor individuals have more elastic demand despite the high speculation in the research community 
(Baicker and Goldman, 2011). They commented that most of the conducted research concentrates 
on the impact of copayments for prescription medication under Medicaid (Stuart and Zacker, 1999; 
Reeder and Nelson, 1985).  
Although previous studies have established that cost-sharing elimination could potentially 
increase preventive health services utilization, many of these studies have not investigated socio-
economic and socio-demographic factors related to preventive services usage. The effect of cost-
sharing elimination on preventive service utilization among individuals with low socioeconomic 
status is limited (Han et al, 2015). To date, only a few studies evaluated the effects of cost-sharing 
on use of cancer preventive services in national samples that represent the population 
(Rezayatmand et al, 2013).  
This study utilized a national sample from the MEPS, which has been extensively used in 
the literature for analysis to draw conclusions that are representative of the national population in 
the US. Furthermore, the inconsistency of previous research evaluating the ACA cost-sharing 
provision could be due to the lack of long periods of time at the time of analysis. The data available 
for preceding analysis was appropriate to assess short-term effects of the provision. Most of the 
studies mentioned in the literature review analyzed data until 2012. In this study, more up-to-date 
data, that was available until 2016, allowed assessment of the long-term effects of the provision. 
In additional, studies lacked methodological approaches that could draw solid conclusions. One 
example of these approaches is to compare changes in the utilization of services to a control group 
which can produce robust conclusions in regards to causality. A recent study examining cancer 
diagnosis among Medicare beneficiaries found a significant increase in early stage CRC cancer 
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diagnosis compared to a younger control group, without evidence of change in breast cancer 
diagnosis (Lissenden and Yao, 2017). Therefore, this study utilized the DID approach that allowed 
for comparison of utilization rates in the treatment group (the insured) to a control group (the 
uninsured) after validating the required assumptions of the DID approach. This study makes a 
significant contribution for policy makers and researchers about the effectiveness of cost related 
policies that could eventually help to increase access to cancer preventive screenings throughout 
the US. 
 
Breast, Cervical and Colorectal Cancer Screening Rates 
A main goal of the Healthy People 2020 is to: “reduce the number of new cancer cases, as 
well as the illness, disability, and death caused by cancer.” Apparently, Healthy People 2020 aims 
is to increase screening for breast, cervical, and CRC cancer as recommended by USPSTF (Office 
of Disease Prevention and Health Promotion, 2017). One way to achieve this goal is to compare 
current rates of screenings with established nationwide targets. An analysis utilizing the 2015 
National Health Interview Survey (NHIS) data, tested trends from 2000 to 2015 and found that 
usage of certain cancer screening tests was significantly below the ideal national targets. These 
national targets were implemented by Health People 2020, which provides national goals to 
improve the health of Americans. The analysis found no increases for breast and cervical cancer 
screenings; however, CRC cancer screenings increased. Differences were found in utilization rates 
among individuals with different races and different socioeconomic backgrounds. 
According to the Centers for Disease Control and Prevention (CDC), mammography usage 
was steady from 2000 to 2015. Mammography usage rate was found to be 71.5% during the last 
two years in 2015 for women aged 50 to 74. This rate remains below the national target of 81.1%. 
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Receiving a mammogram was lowest among American Indians/Alaska Natives with a rate of 
56.7%. The results indicated that women who were educated and had a higher-income level 
received more mammograms. Women who were uninsured and who did not have a continuous 
source of health care reported the lowest mammography rates (White et al, 2015). Cervical cancer 
screening, particularly the pap smear test, declined from 2000 to 2015. In 2015, only 83% of 
women had cervical cancer screening. This rate remains beneath the Healthy People 2020 
established target of 93.0%. The pap test utilization was the lowest among Asian women with a 
rate of 75.8%. Also, women of the age group between 21 and 30 years old had lowest cervical 
cancer screening usage. Like mammography, the results indicated that women who were educated 
and had a higher-income level received more cervical cancer screenings. Furthermore, women 
who were uninsured and who did not have a continuous source of health care reported the lowest 
cervical cancer screening rates (White et al, 2015). 
CRC cancer screening increased from 2000 to 2015 to 62.4%; however, the rate remains 
beneath the Healthy People 2020 established target of 70.5%. CRC screening use was lowest 
among American Indians/Alaska Natives with a rate of 48.4%. Also, CRC screening was lower 
among individuals aged 50–64 years than among individuals aged 65–75 years even though the 
guidelines recommend screening starting at age 50. Moreover, the percentage of individuals who 
reported having a CRC cancer screening increased with increasing education and income levels. 
Moreover, individuals who were uninsured and who did not have a continuous source of health 
care reported the lowest CRC screening rates (White et al, 2015). 
Despite forceful determination to increase mammography, cervical, and CRC cancer 
screenings during the last few years, test screenings proportions remain substandard. As mentioned 
earlier, one of the ACA goals is to increase the rates of screenings through total coverage of these 
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screening tests without any cost-sharing incurred by the patient. One of the strategies shown to 
increase utilization of preventive services is removing cost barriers that are incurred by patients to 
receive these services. Patients with private insurance and Medicare were responsible to bear some 
costs to their CRC screening services before the ACA through co-insurance, copayment, and 
deductibles. This cost responsibility created a burden on patients, especially with expensive 
procedures such as colonoscopy and sigmoidoscopy. The cost of cancer screening tests is usually 
very high. For example, Medicare charged patients in 2008 for mammograms between $82 and 
$115. Also, the permissible charge for patients under Medicaid was between $642 and $842 for 
colonoscopy in 2008. Medicare patients had a permissible charge for colonoscopy that ranged 
between $642 to $842 before the ACA (Fedewa et al, 2015). Furthermore, Medicaid patients had 
a permissible charge that ranged between $130 to $200 for sigmoidoscopy (Cokkinides et al, 
2011). Therefore, identifying whether the cost-sharing elimination provision changed the 
utilization of breast, cervical, and CRC cancer screening is important to understand if it had the 
policy desired effects and if financial barriers are the main reason for suboptimal screening rates. 
PUBLIC HEALTH SIGNIFICANCE 
One of the central reasons of the ACA cost-sharing elimination provision is to promote 
awareness about the importance and effectiveness of preventive services in improving an 
individual’s quality of life, wellness, and health outcomes. One of the primary long-term public 
health goals of the US health care system is to have better preventive care services that will 
eventually lead to improving population health and reduce health-related spending. This goal could 
be achieved by formulating and implementing policies that ensure continuous screenings and 
management of chronic conditions; by promoting access to preventive health services in removing 
financial barriers; and by monitoring the accessibility and quality of care. 
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Preventive care screening services for breast, cervical, and CRC cancer are imperative 
since they have a high capability to lessen the burden of cancer in the United States (Maciosek et 
al, 2009). Despite the significant efforts that have been made to increase cancer screenings, 
screening rates for breast, cervical, and CRC cancer remain suboptimal and disappointingly low 
(Office of Disease Prevention and Health Promotion, 2017). The monetary costs of cancer are high 
for both the individual with cancer and for the society as a whole. The Agency for Healthcare 
Research and Quality (AHRQ) estimates that the direct medical costs for cancer in the US in 2015 
were $80.2 billion. This year, around 609,640 Americans are predicted to die from cancer which 
is approximately 1,670 persons a day (American Cancer Society, 2018). After heart disorders, 
cancer is the second most common cause of death in the US. The implementation of the cost-
sharing elimination provision will help address this through the elimination of financial barriers 
that prevent individuals from getting the screenings. 
The main goals of public health are to promote and protect health, prevent death and 
injuries, and prolong lives (Munthe et al, 2008). The implementation of the ACA is a powerful 
step that could eventually help to achieve the three goals of public health by removing financial 
barriers and promoting access to preventive care. This dissertation will help to evaluate the effect 
of the recent cost-sharing elimination provision under the ACA on cancer screenings rates and 
disparities among different groups, which would provide information to policy makers and health 
professionals on whether the cost-sharing elimination provision produced the intended results. If 
that was not the case, other reasons for suboptimal cancer screening rates could be evaluated. It is 
evident that better health coverage and enhanced access are essential; however, they could not be 
adequate to achieve optimal utilization of preventive care services.  
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AIMS AND OBJECTIVES 
This study investigated the impact of the ACA cost-sharing elimination provision on the 
utilization of three cancer prevention screenings. Specifically, the current study evaluated changes 
in breast, cervical, and CRC cancer screening utilization, among individuals who were privately 
insured and/or Medicare-insured, before and after the cost-sharing elimination provision was 
enacted. This provision became effective for private health insurance plans, in 2010, and for 
Medicare, in 2011. A focus of this dissertation was on the influence of socio-economic and socio-
demographic factors on utilization changes. This study utilized the national Medical Expenditure 
Panel Survey (MEPS) data, from 2008 through 2016, for the analyses. The results of this 
dissertation expanded the current knowledge of the impact of the ACA cost-sharing elimination 
provision in increasing utilization of five imperative cancer screening services including 
mammography, pap smear, FOBT, colonoscopy and sigmoidoscopy.  
Aims 
Aim 1: To evaluate changes in receipt of breast cancer (i.e. mammography) and cervical 
cancer screening (i.e. pap smear) services pre-and post implementation of the ACA cost-
sharing elimination provision, from 2008 through 2016, using MEPS. 
• Objective 1: To determine whether the utilization of mammography and the pap smear test 
increased after the implementation of the cost-sharing elimination provision among private 
and/or Medicare-insured women in the United States.  
• Objective 2: To examine whether differences in medical utilization of mammography and 
the pap smear test result from differences in socio-economic and socio-demographic 
factors, as measured by predisposing, enabling and need predictors of resource use. 
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Aim 2: To evaluate changes in receipt of colorectal cancer (CRC) screening services pre-and 
post implementation of the ACA cost-sharing elimination provision, from 2008 through 2016 
using MEPS. 
• Objective 1: To determine whether the utilization of CRC cancer screening increased after 
the implementation of the cost-sharing elimination provision among private and/or 
Medicare-insured individuals in the United States. 
• Objective 2: To examine whether differences in medical utilization of CRC cancer 
screening services result from differences in socio-economic and socio-demographic 
factors, as measured by predisposing, enabling and need predictors of resource use. 
 
CONCEPTUAL FRAMEWORK 
The Health Behavior Model, or widely known as the Andersen’s Behavioral Model of 
Health Services Use (BM), will be applied to examine the relationship between preventive services 
utilization and cost-sharing elimination with the focus on specific socioeconomic factors 
(Andersen et al, 2001). The BM was selected to guide independent variables selection for our 
analysis since it is a well-established model used in studies that investigate health care services 
utilization.  It is a multilevel model that includes determinants of health services utilization at 
individual and contextual levels. The BM was developed by Ronal M. Andersen, Aday and others 
in 1968 and it explains the effect of the predisposing, enabling, and need factors on patient 
utilization of health care services (Andersen, 1995). The model will help to understand the factors 
that affect health utilization and is useful to assess the reasons for differences in utilization by 
socio-economic and socio-demographic factors.  
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For the study purposes, health behavior is identified as the utilization of preventive care 
services. Figure 1 represents the schematic view of our research model highlighting the dependent 
variable (health behavior), all explanatory variables, and control variables. The figure illustrates 
the BM model and the means in which the predisposing, enabling, and need factors impact health 
services utilization.  
Next, the study explores the socio-economic and socio-demographic factors, deriving 
evidence from prior research conducted about utilization of preventive services and based on the 
work of Andersen & Davidson about these factors (Andersen and Davidson, 2001). Each of the 
aims of this dissertation will utilize the BM Model as the foundation to identify the factors that 
explain the use of cancer screening services, specifically, breast, cervical and CRC cancer 
screenings.  
Predisposing factors 
According to the BM model, predisposing factors comprise the factors that influence 
individuals to use health services including demographic characteristics such as age and sex, social 
factors such as education, employment, race, ethnicity, social relationships, health beliefs, and 
socio-economic characteristics. Socio-economic characteristics tend to have an influence on 
healthcare utilization in general. For example, patients of lower socioeconomic status have higher 
rates of chronic conditions, which implies a differential effect of cost-sharing policies on their 
utilization of services. Moreover, patients with low socioeconomic status were found to be less 
adherent to treatment protocols for their chronic conditions and thus have worse health outcomes 
(Goldman and Smith, 2002). 
The literature usually measures socioeconomic disparities by income, education, and 
occupation. It is apparent that individuals with higher income, education, and better occupations 
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would have more access to resources that are connected to being healthier, such as healthcare 
services, healthier lifestyles, nutritious behaviors, and others (Zimmerman, Woolf & Haley, 2014). 
The cost-sharing provision is expected to reduce the socioeconomic disparities in health across 
those individuals.  
 There are disparities by race and socioeconomic factors that were documented in the 
literature in regards to utilization of preventive services. These disparities indicate that minorities, 
such as Hispanics and blacks were, in general, less likely than whites to receive preventive services 
such as cholesterol screening, blood pressure checks, and cancer screenings (Gornick, 2000). 
White women received more cervical and breast cancer screening services compared to women 
from other races including black Americans (Nadpara et al, 2012; Bhanegaonkar et al, 2012). 
Another study reported contradictory findings indicating that minority women in specific 
communities were more likely to receive cervical and breast cancer screenings (Cook et al., 2010; 
Coronado, Thompson, and Chen, 2009). Moreover, there were disparities by age that were 
documented in the literature. For example, it has been reported that age is negatively associated 
with mammograms and positively associated with pap smears, cholesterol, and blood pressure 
screenings (Holden, Chen and Dagher, 2015).   
 Education is also a factor that could impact preventive care service utilization. In a study 
of medication copayments under Medicaid, low-income individuals were found to make fewer 
well-informed decisions because of their poor communication skills with their physicians as a 
result of a positive correlation between education and income (Reeder and Nelson, 1985). Higher 
levels of education are associated with greater utilization of preventive health care services 
(Hewitt, Devesa and Breen, 2002).  
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Enabling/Impeding factors 
In general, enabling/impeding factors are the resources available to individuals to utilize 
health services such as income, health insurance, and continuity of care. Enabling factors are also 
defined as the financing and organizational factors that enable conditions that influence health care 
utilization. The financing factors are specifically related to the income level of individuals that 
allow them to pay for health services. These factors are associated with health insurance coverage 
and cost-sharing requirements. Organizational factors involve the sources and continuity of care.  
Chandra et al, (2014) argued that cost-sharing could have a different impact on low-income 
patients who sometimes tend to avoid care with the lowest marginal benefit because of their 
financial constraints. Several other studies showed that having a higher income is associated with 
increased preventive service use (Chernew et al, 2007). For example, out-of-pocket payments can 
enable or impede the use of health services depending on their amounts. Cost-sharing has been 
reported as an impediment to receive preventive services and thus removing this barrier is 
important to increase utilization (Solanki et al, 2000). Further, in a study about the utilization of 
preventive services recommended by the USPSTF, receipt of services was strongly positively 
associated with having insurance coverage and a constant source of care (DeVoe et al, 2003). 
Several studies also determined this positive association (Bednarek & Schone, 2003; Bandi et al, 
2012; Allen et al, 2009). 
Need factors  
    Need factors include individuals perceived need for health services such as their functional 
status, previous conditions, or health risks. Need factors include perceived or evaluated health 
complications that either patients or health care providers decide that they need medical service 
intervention (Andersen, 1995). Several studies showed that having certain risk factors could 
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increase the probability of using some preventive services. For example, a study reported that 
overweight and obese men received more cholesterol and glucose screening but less CRC cancer 
screenings or prostate cancers screenings (Quinn et al, 2012). Another study found that an 
increasing body mass index (BMI) was associated with increased utilization of preventive services 
(Shires et al, 2012).  
Although it might be projected that individuals with more risk factors are more likely to 
seek certain preventive services, several studies showed that individuals who have asthma and who 
are smokers were significantly less likely to receive an influenza vaccine despite their risky 
situations (Lu et al, 2009; Vander et al, 2012). Despite their increased risk of cancer, daily smokers 
were found to be less likely to receive cancer screening (Vander et al, 2012). Patients of lower 
socioeconomic status have higher rates of chronic conditions, which imply differential effect of 
cost-sharing policies on their utilization of services. A study examining the relationship between 
the and being up-to-date on cancer screenings found an increase in screenings with specific types 
of chronic conditions rather than the total number of conditions (Liu et al, 2014). Contrariwise, 
several studies have found that the number of chronic diseases is correlated with increased cancer 
screenings. For example, hypertensive individuals had more breast exams, pap smears, FOBTs, 
and a trend to have more mammograms (Heflin et al, 2002). Also, women with three or more 
chronic conditions were shown to have more mammograms, pap smears, and breast exams 
(Yasmeen et al, 2011; Zao et al, 2008).  
In summary, prior studies have shown conflictive results for the impact of predisposing, 
need, and enabling factors on cancer preventive care usage. Therefore, to have more robust 
evidence, this study focuses on the inclusion of socio-demographic and socio-economic factors 
that had some evidence to impact utilization. By including all these factors, as covariates, in the 
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DID the model, they will provide more precise information about the change in the main outcomes 
of cancer screenings. 
Figure 1. Study Model 
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METHODS 
Data Source 
This study utilized the Medical Expenditure Panel Survey (MEPS), which is a part of the 
US Department of Health and Human Services data that includes national and regional estimates 
of numerous aspects of healthcare. The MEPS is a nationally representative survey of non-
institutionalized US individuals, their families, and their medical providers (physicians, hospitals, 
pharmacies, etc.), which is sponsored by the Agency for Healthcare Research and Quality 
(AHRQ). The MEPS has three main components: the primary Household Component, the 
Insurance/Employer Component, and the Medical Provider Component. This study utilized the 
Household Component that is publicly available (AHRQ, 2016). More information about the 
MEPS survey design and content is available from the MEPS website (AHRQ, 2016). 
The MEPS is widely used by prominent medical researchers, as well as the government, to 
evaluate the health care system. One of the most important advantages of the MEPS survey is that 
it is done on a constant basis which delivers researchers with useful and timely information. The 
MEPS was created in 1996 to provide more opportune information about the developing health 
care system in the US. The MEPS initiates a new panel of households into the survey each year. 
The MEPS has a panel design that includes five series of interviews covering two full years. It 
collects data on the usage of health services, their costs, the ways these services are paid for, and 
health insurance coverage. It provides data, at the individual participant level, on the socio-
economic and socio-demographic characteristics of survey participants (Ezatti-Rice, Rohde, and 
Greenblatt, 2008). The data is conveyed by a particular household respondent. Respondents 
answer questions over five interviews during a two-and-a-half-year period. Questions in the 
Household component include demographic characteristics, health conditions, health status, 
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utilization of medical care, charges and payments, access to care, insurance coverage, income, 
education and employment (Cohen et al, 2009). 
The MEPS Household Component collects information about health insurance coverage 
by person and family-level characteristics. The MEPS contains a constructed variable that 
summarizes health insurance coverage for any individual with three different values: 1= any 
private (having any type of private insurance (including TRICARE/CHAMPVA), 2= public 
insurance, 3= uninsured. There are other insurance coverage variables that indicate the type of 
public health coverage that an individual has. For this study sample, all individuals with 
Medicaid coverage were excluded from the sample. Only individuals with private and/or with 
Medicare coverage were included in the study sample. The MEPS categorizes TRICARE as 
private coverage. In this study, TRICARE was categorized as a type of private coverage, 
similarly as in the MEPS data.  
This study analyzed nine years of pooled MEPS data (2008 through 2016) and examined 
changes in the use of five cancer preventive screening services including mammography, pap 
smear, FOBT, colonoscopy and sigmoidoscopy, before and after the implementation of the ACA 
cost-sharing elimination provision, focusing on the effect of specific socio-demographic and socio-
economic factors. The analysis was conducted in 2019. 
Study Design 
A quasi experimental difference-in-differences (DID) approach was used to estimate the 
effect of the ACA cost-sharing elimination provision on cancer preventive services by comparing 
the changes of breast, cervical and CRC cancer screening rates between individuals who benefitted 
from this provision (the insured) and individuals who did not (the uninsured). The DID approach 
has become an increasingly prevalent method to estimate causal relationships and it is used to 
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estimate the effect of a specific intervention (such as an enactment of a law, or a program 
implementation), by comparing the changes in outcomes over time between a population that is 
enrolled in a program (the intervention group) and a population that is not (the control group) 
(Dimick & Ryan, 2014). 
DID is normally utilized in observational settings and it assumes that in absence of 
treatment, the unobserved differences between treatment and control groups are the same overtime 
(Dimick & Ryan, 2014). DID requires data from pre/post intervention period for both the treatment 
and control groups; it is a valuable method to use when randomization on the individual level is 
not possible (Wing et al, 2018). The DID technique calculates the effect of a treatment 
(independent variable) on an outcome (dependent variable) by comparing the average change over 
time in the outcome variable for the treatment group, compared to the average change over time 
for the control group (Dimick & Ryan, 2014). Thus, the DID technique was the best approach to 
improve the internal validity of our analysis and to account for possible secular trends. 
One of the most important assumptions in the DID methodology is that trends in the 
outcomes before the intervention are parallel across the treatment and control groups (Wing et al, 
2018). That means, in the nonexistence of the policy, the two groups would have continued to 
change with matching trends (Angrist & Pischke, 2009). For this study, the parallel trend 
assumption between insured (treatment) and uninsured individuals (control) was not violated for 
any of the cancer screening services examined (Figures 2, 3, 4, 5, and 6). 
 For this study, the DID approach was applied to the regression estimations by comparing 
results before and after the introduction of the independent variable in 2010, which is the ACA 
cost sharing-elimination provision for preventive care services, between insured and uninsured 
individuals. The USPSTF recommendations for the selected cancer preventive services were 
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adopted to measure odds of receipt by socio-demographic and socio-economic factors. The 
primary dependent variable and covariates representing the socio-demographic and socio-
economic factors are discussed in the section below. 
Study Measures  
Primary Dependent Variables 
The primary dependent variable for each logistic regression model is self-reported receipt 
of the cancer screening service. Five preventive cancer screenings were analyzed, including 
mammography for breast cancer screening, the pap smear for cervical cancer screening, FOBT, 
colonoscopy and sigmoidoscopy for CRC cancer screening. Receipt of each screening is defined 
as having the screening service within the interval period and age requirements set by the USPSTF 
guidelines. 
In the MEPS survey, respondents were asked about the last time they received a screening 
test. The respondents had to choose an answer from a few given options including if they have 
received the screening test during the last year, two years, etc. Receipt of each cancer screening 
service had a binary outcome of (yes, no). Table 4 summarizes the examined cancer screening 
services by the recommended population, frequency of assessment, and the MEPS survey 
questions.  
Table 4. Breast, Cervical, and CRC screening services recommended population, 
frequency of assessment, and the MEPS survey questions. 
Screening Recommended 
Population 
Frequency MEPS Survey 
Questions 
Breast Cancer 
(Mammogram) 
Women aged 50-74 Every 2 years How long since last 
mammogram? 
Cervical Cancer (Pap 
Smear) 
Women aged 21-65 Every 3 years How long since last 
pap smear test? 
Colorectal Cancer  
Fecal Occult Blood 
Adults aged 50-75 
 
FOBT yearly or, 
 
When was last 
FOBT? 
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Test (FOBT) 
 
Colonoscopy 
 
 
Sigmoidoscopy 
 
 
Colonoscopy every 
10 years, or 
 
Sigmoidoscopy 
every 5 years with 
FOBT every 3 years 
 
When was last 
colonoscopy? 
 
When was last 
sigmoidoscopy? 
Source: US Preventive Services Task Force Website 
Independent Variables  
Primary Independent Variables 
The primary independent variables are POST, INSURED, and POST*INSURED. The 
variable POST is defined as the period after the implementation of the ACA provision (2008 to 
2010 vs 2011 to 2016). The variable POST indicates whether the period is post or pre-ACA 
intervention, which is a key variable in every DID estimation model. Including POST in the 
equation manages the time trend problem and shows utilization differences among the uninsured 
(the control group) after the ACA provision. The variable INSURED, which is considered as an 
enabling factor, is a dummy variable that shows the differences between the treatment (insured 
individuals) and control (uninsured individuals) groups in the pre-period. Finally, the variable 
POST*INSURED is an interaction term that provides the actual estimated effect of the policy 
intervention. It is the difference in the treatment group before and after ACA implementation 
minus the difference in the control group before and after the ACA implementation. In other words, 
the interaction of post and insurance shows how insured individuals changed their utilization of 
the five examined cancer screenings after the ACA provision.  
 
Covariates: 
The choice of covariates, including other socio-demographic and socio-economic factors, 
was guided by the BM model and the preceding literature related to cancer screening determinants. 
Predisposing factors included age, gender (only for CRC cancer screening), race, ethnicity, marital 
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status, education, and employment. Enabling factors included income, insurance status, regular 
source of care, number of visits, region, and residence. Health needs factors included perceived 
health status, number of chronic conditions, smoking status and body mass index (BMI). 
Table 5 lists all the independent variables that were perceived to have an impact on the dependent 
variables. The variables were categorized according to the BM model as predisposing, enabling, 
and/or need factors. 
Table 5. Independent Variables 
Predisposing Factors 
Independent 
Variable 
Definition Measurement 
Age Person’s age Continuous 
Gender* Person’s gender Dichotomous,1=Female, 
0=Male 
Race Person’s race Categorical, 1=White, 
2=Black, 3=American 
Indian/Alaska native, 
4=Asian, 5=Native 
Hawaiian/Pacific islander, 
6=Multiple races 
Ethnicity Person’s ethnicity Dichotomous, 1=Hispanic, 
0=Non-Hispanic 
Marital Status Patients’ marital status Dichotomous, 1=Married, 
0=Not married 
Education Person’s educational attainment Ordinal, 1=Less than high 
school, 2=High school, 
3=Some college, 4=Four 
year of college or more 
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Employment Person’s employment status Continuous 
Enabling Factors 
Independent 
Variable Definition Measurement 
Income 
 
Indicates person’s total Income Continuous 
Insured Indicates whether a person is insured, or 
uninsured 
Dichotomous, 1=Insured, 
0=Not Insured 
Regular source 
of care 
Indicates whether there is a doctor’s 
office, clinic, health center, or place that 
the individual usually goes to if he/she 
needs to 
Dichotomous, 1=Yes, 2=No 
No. of visits to 
care 
Indicates number of office based 
provider visits 
Numerical 
Region Indicates the Census region for the 
person 
 
Categorical, 1=Northeast, 
2=Midwest, 3=South 4=West 
Residence  Indicates whether the person is found in 
a Metropolitan Statistical Area  
Dichotomous, 1=MSA, 0= 
non-MSA  
Need Factors 
Independent 
Variable Definition Measurement 
Perceived Health 
Status 
Person’s perceived health status Ordinal, 1=Excellent, 
2=Very good, 3=Good, 
4=Fair, 5=Poor 
An average of the results was 
considered 
Number of 
chronic 
conditions 
Indicates whether a doctor or other 
health professional ever told the person 
they had high blood pressure, heart 
disease (including coronary heart 
disease, angina, myocardial infarction, 
Numerical 
 
 44 
and other unspecified heart disease), 
stroke, emphysema, high cholesterol, 
cancer (including cancer type), diabetes, 
arthritis, or asthma.  
Smoking Status Person’s smoking status Dichotomous, 
1=Yes, 2=No 
BMI Person’s Body Mass Index Continuous 
  * The gender variable was only included for the second aim 
 
 
 
ANALYSIS 
To address both aims, the study sample was summarized and descriptive statistics were 
computed (i.e. mean, standard deviation and/or proportion) on all predisposing, enabling, and need 
variables (independent variables). In addition, to determine if there was a significant difference 
between the means of the variables before and after the policy provision, two samples t-tests were 
conducted (Table 8). T-tests were performed under the assumption that variables fit a normal 
distribution. All the statistical analysis was conducted using STATA version 15. Approval for this 
study was obtained from the Committee for the Protection of Human Subjects at the University of 
Texas, Health Science Center at Houston. 
Addressing Aim 1 
Aim 1: To evaluate changes in receipt of breast (i.e. mammography) and/or cervical (i.e. pap 
smear) cancer screening services pre-and post implementation of the ACA cost-sharing 
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elimination provision, from 2008 through 2016, using MEPS. 
• Objective 1: To determine whether the utilization of mammography and/or pap smear 
increased after the implementation of the cost-sharing elimination provision among private 
and/or Medicare-insured women in the United States.  
• Objective 2: To examine whether differences in medical utilization of mammography 
and/or pap smear result from differences in socio-economic and socio-demographic 
factors, as measured by predisposing, enabling and need predictors of resource use. 
Aim 1-Hypothesis 
The utilization of mammography and/or pap smear increased after the implementation of 
ACA cost-sharing elimination among privately and/or Medicare insured women in the US as 
access to preventive care services increased under the ACA.  
Aim 1-Sample  
For mammography, the sample included women, aged 50 to 74 years, as per the 2009 
USPSTF recommendations. For pap smear, the sample included women, aged 21 to 65 years, as 
per the 2012 USPSTF recommendations. Both groups were included because the provision directly 
applies to them. For the DID analysis, uninsured women with equivalent age groups for each 
cancer screening were included as a control group because they were not impacted by the 
provision. Women under Medicaid coverage were excluded since participating in Medicaid 
expansion under the ACA was optional for states (Wilensky and Gray, 2013). Women with breast 
and/or cervical cancer, had surgery, or were diagnosed with conditions related to breast and/or 
cervical cancer were excluded from the sample. In addition, women were excluded if they had 
missing responses for the required period. Table 6 lists specific guidelines, USPSTF 
recommendation grades, and the study target population for both mammography and pap smear. 
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Table 6. Specific Guidelines/Study Population for Mammography and Pap Smear 
Preventive Service 
(year) Recommendation (grade) 
Study Target 
Population Screening interval 
Mammography 
(2009) 
The USPSTF recommends 
mammography every two years 
for women aged 50 to 74. (B) 
Women aged 
50-74 and not 
diagnosed 
with breast 
cancer 
Every 2 years 
(Biennial) 
 
Pap Smear (2012) 
The USPSTF recommends 
screening for cervical cancer in 
women age 21 to 65 years with 
cytology (Pap smear) every 3 
years or, for women age 30 to 
65 years who want to lengthen 
the screening interval, screening 
with a combination of cytology 
and human papillomavirus 
(HPV) testing every 5 years. (A) 
Women aged 
21-65, not 
diagnosed 
with cervical 
cancer, and 
who have a 
cervix 
 
Pap smear every 3 
years or pap smear 
and HPV testing 
every 5 years 
Source: US Preventive Services Task Force Website 
Aim 1-Analysis 
To address objective 1, a proportions test was conducted to illustrate the proportion of 
women who received mammography and/or pap smear out of the number of women who were 
recommended to receive mammography and/or pap smear, before and after the ACA provision. In 
addition, to determine if there was a significant difference between the values before and after the 
policy provision, two samples t-tests were conducted. Table 9 shows the results of proportions test. 
Furthermore, a trend analysis was performed visualizing yearly rates of being up-to-date on 
mammogram and/or pap smear before and after the ACA provision to observe if there are changes 
overtime. Figure 2 and 3 demonstrate the change in mammography and pap smear utilization rates 
before and after the ACA provision.  
To address objective 2, logistic regression models were estimated to measure the receipt of 
mammography and pap smear controlling for all the predisposing, enabling, and need variables 
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that are listed in table 5. Estimates of the impact of the policy on mammography and pap smear 
were estimated by fitting four logistic regression models for each screening service that 
incorporated a DID estimator. The first model was an unadjusted model that only controlled for 
insurance status and period of screening (whether it was pre-or post the ACA provision). The 
second model was an adjusted model that controlled for predisposing variables including age, race, 
ethnicity, marital status, education and employment. The third model was additionally adjusted by 
controlling for enabling factors including income, regular source of care, number of visits to care, 
region and residence. The fourth and final regression model was further adjusted by controlling 
for need factors including perceived health status, number of chronic conditions, smoking status, 
and BMI. In order to select the model with the best possible fit, AIC values were generated to 
show the quality of each model. The fourth model including all variables had the lowest AIC, 
indicating the best fit for the logistic regression estimation. The regression models estimated the 
odds ratios for all the independent variables and the corresponding 95% confidence intervals. The 
regression analysis tested all women who had at least one recommended mammography or pap 
smear against the independent variables that could have an influence on a women’s decision to 
obtain the screenings. The primary variable of interest was the interaction term between the time 
variable POST and the treatment group variable, INSURED. The first DID model examined the 
receipt of mammography. The second DID model examined the receipt of pap smear.  
Aim 1-Model Specifications 
Model Specification 1 (for mammography):  
Y=β0 + β1*POST + β2*INSURED + β3*POST *INSURED+ ∑Xβn + ε 
For the model estimated in this analysis, the DID estimation is explained by Y, which is the 
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outcome of interest being the utilization rate of mammography, INSURED is a dummy variable 
equal to 1 when women were insured and 0 when women were uninsured, POST is a time dummy 
variable equal to 1 if the time is after the ACA policy intervention and equal to 0 if the time is 
before the ACA policy intervention, X is a vector of predisposing, enabling, and need variables. 
The coefficient β0 is the Y intercept, the utilization for the pre-intervention period, for the control 
group, when all control variables are equal to zero. The coefficient β1 is the time trend in the 
control group. It is equal to the difference in utilization among the uninsured (the control group) 
after the ACA provision. The coefficient β2 is the difference between the control and treatment 
groups pre- intervention. The coefficient of the interaction (POST*INSURED) is the coefficient of 
interest β3 which is the difference in differences term. It represents the difference of changes over 
time. β3 is the DID estimator that measures the effect of the policy intervention on insured women. 
Finally, the coefficient βn represents how Y changes when a single covariate changes holding other 
variables in the model constant. 
Model Specification 2 (for the pap smear test):  
Y=β0 + β1*POST + β2*INSURED + β3*POST *INSURED+ ∑Xβn + ε 
For the model estimated in this analysis, the DID estimation is explained by Y, which is the 
outcome of interest being the utilization rate of pap smear, INSURED is a dummy variable equal 
to 1 when women were insured and 0 when women were uninsured, POST is a time dummy 
variable equal to 1 if the time is after the ACA policy intervention and equal to 0 if the time is 
before the ACA policy intervention, X is a vector of predisposing, enabling, and need variables. 
The coefficient β0 is the Y intercept, the utilization for the pre-intervention period, for the control 
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group, when all control variables are equal to zero. The coefficient β1 is the time trend in the 
control group. It is equal to the difference in utilization among the uninsured (the control group) 
after the ACA provision. The coefficient β2 is the difference between the control and treatment 
groups pre- intervention. The coefficient of the interaction (POST*INSURED) is the coefficient of 
interest β3 which is the difference in differences term. It represents the difference of changes over 
time. β3 is the DID estimator that measures the effect of the policy intervention on insured women. 
Finally, the coefficient βn represents how Y changes when a single covariate changes holding other 
variables in the model constant. 
Addressing Aim 2 
Aim 2: To evaluate changes in receipt of colorectal cancer (CRC) screening services pre-and 
post implementation of the ACA cost-sharing elimination provision, from 2008 through 2016 
using MEPS. 
• Objective 1: To determine whether the utilization of CRC cancer screening increased after 
the implementation of the cost-sharing elimination provision among private and/or 
Medicare-insured individuals in the United States. 
• Objective 2: To examine whether differences in medical utilization of CRC cancer 
screening services result from differences in socio-economic and socio-demographic 
factors, as measured by predisposing, enabling and need predictors of resource use 
Aim 2-Hypothesis 
The utilization of CRC cancer screening tests including FOBT, colonoscopy and 
sigmoidoscopy, increased after the implementation of ACA cost-sharing elimination among 
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privately and/or Medicare insured individuals in the US as access to preventive care services 
increased under the ACA.  
Aim 2-Sample  
For CRC cancer screenings, the sample included survey respondents including individuals 
aged 50 to 75 years, as per the 2008 USPSTF recommendations. For the DID analysis, uninsured 
individuals with equivalent age groups for each CRC cancer screening were included as a control 
group because they were not impacted by this provision. Individuals under Medicaid coverage 
were excluded since participating in Medicaid expansion under the ACA was optional for states 
(Wilensky and Gray, 2013). Individuals with colon cancer, had surgery, or were diagnosed with 
conditions related to colon cancer were excluded from the sample. In addition, individuals were 
excluded if they had missing responses for the required period.  
Table 7. Specific Guideline and Study Population for CRC Cancer Screening 
Preventive Service 
(year) Recommendation (grade) 
Study Target 
Population Screening interval 
Colorectal cancer 
screening (2008) 
The USPSTF recommends 
screening for CRC cancer using 
fecal occult blood testing 
(FOBT), sigmoidoscopy, or 
colonoscopy for adults aged 50 
to 75 years. (A) 
Adults aged 
50-75 and not 
diagnosed 
with colon 
cancer 
 
Colonoscopy: every 
10 years 
Sigmoidoscopy: 
every 5 years when 
combined with 
FOBT 
Blood stool test: 
every year 
Source: US Preventive Services Task Force Website 
Aim 2-Analysis  
To address objective 1, a proportions test was conducted to illustrate the proportion of 
individuals who received FOBT, colonoscopy and/or sigmoidoscopy out of the number of 
individuals who were recommended to receive them, before and after the ACA provision. In 
addition, to determine if there was a significant difference between the values before and after the 
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policy provision, two samples t-tests were conducted. T-tests were performed under the 
assumption that variables fit a normal distribution. Table 12 shows the results of proportions test 
for FOBT, colonoscopy, and sigmoidoscopy. Furthermore, a trend analysis was performed 
visualizing yearly rates of being up-to-date on these CRC cancer screenings before and after the 
policy in order to see if there were changes overtime. Figure 4, 5, and 6 demonstrate the change in 
FOBT, colonoscopy and/or sigmoidoscopy utilization rates before and after the ACA provision. 
To address objective 2, logistic regression models were estimated to measure the receipt of 
FOBT, colonoscopy and sigmoidoscopy controlling for all the predisposing, enabling, and need 
variables that are listed in table 5. For the DID models, estimates of the impact of the policy were 
determined by fitting four logistic regression models for each screening service. The first model 
was an unadjusted model that only controlled for the insurance status and the period of screening 
(whether or not it was pre-or post the ACA). The second model was an adjusted model that 
controlled for predisposing variables including age, race, ethnicity, marital status, education and 
employment. The third model was further adjusted by controlling for enabling factors including 
income, regular source of care, number of visits to care, region and residence. The fourth and final 
regression model was further adjusted by controlling for need factors including perceived health 
status, number of chronic conditions, smoking status, and BMI. To select the model with the best 
possible fit, AIC values were generated to show the quality of each model. The fourth model, 
which is the full model, had the lowest AIC, indicating that it is the best fit for the logistic 
regression estimation. The regression models estimated the odds ratios for all the independent 
variables and the corresponding 95% confidence intervals. The regression analysis tested all 
individuals who had at least one recommended CRC screening against the independent variables 
that could have an influence on the individual’s decision to obtain the screenings.  
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The logistic regression model was estimated using a DID method. The DID was 
implemented as an interaction term between the time variable, POST, and the treatment group 
variable, INSURED in the logistic regression model. By using this method, a comparison of 
utilization of CRC cancer screenings was conducted between insured and uninsured individuals, 
before and after the ACA. The first DID model examined the receipt of FOBT. The second DID 
model examined the receipt of colonoscopy. The third DID model examined the receipt of 
sigmoidoscopy. 
Aim 2-Model Specifications 
Model Specification 3 (for FOBT):  
Y=β0 + β1*POST + β2*INSURED + β3*POST *INSURED+ ∑Xβn + ε 
For the model estimated in this analysis, the DID estimation is explained by Y, which is the 
outcome of interest being the utilization rate of FOBT, INSURED is a dummy variable equal to 1 
when individuals were insured and 0 when individuals were uninsured, POST is a time dummy 
variable equal to 1 if the time is after the ACA policy intervention and equal to 0 if the time is 
before the ACA policy intervention, X is a vector of predisposing, enabling, and need variables. 
The coefficient β0 is the Y intercept, the utilization for the pre-intervention period, for the control 
group, when all control variables are equal to zero. The coefficient β1 is the time trend in the 
control group. It is equal to the difference in utilization among the uninsured (the control group) 
after the ACA provision. The coefficient β2 is the difference between the control and treatment 
groups pre- intervention. The coefficient of the interaction (POST*INSURED) is the coefficient of 
interest β3 which is the difference in differences term. It represents the difference of changes over 
time. β3 is the DID estimator that measures the effect of the policy intervention on insured 
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individuals. Finally, the coefficient βn represents how Y changes when a single covariate changes 
holding other variables in the model constant. 
Model Specification 4 (for colonoscopy):  
Y=β0 + β1*POST + β2*INSURED + β3*POST *INSURED+ ∑Xβn + ε 
For the model estimated in this analysis, the DID estimation is explained by Y, which is the 
outcome of interest being the utilization rate of colonoscopy, INSURED is a dummy variable equal 
to 1 when individuals were insured and 0 when individuals were uninsured, POST is a time dummy 
variable equal to 1 if the time is after the ACA policy intervention and equal to 0 if the time is 
before the ACA policy intervention, X is a vector of predisposing, enabling, and need variables. 
The coefficient β0 is the Y intercept, the utilization for the pre-intervention period, for the control 
group, when all control variables are equal to zero. The coefficient β1 is the time trend in the 
control group. It is equal to the difference in utilization among the uninsured (the control group) 
after the ACA provision. The coefficient β2 is the difference between the control and treatment 
groups pre- intervention. The coefficient of the interaction (POST*INSURED) is the coefficient of 
interest β3 which is the difference in differences term. It represents the difference of changes over 
time. β3 is the DID estimator that measures the effect of the policy intervention on insured 
individuals. Finally, the coefficient βn represents how Y changes when a single covariate changes 
holding other variables in the model constant. 
Model Specification 5 (for sigmoidoscopy):  
Y=β0 + β1*POST + β2*INSURED + β3*POST *INSURED+ ∑Xβn + ε 
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For the model estimated in this analysis, the DID estimation is explained by Y, which is the 
outcome of interest being the utilization rate of sigmoidoscopy, INSURED is a dummy variable 
equal to 1 when individuals were insured and 0 when individuals were uninsured, POST is a time 
dummy variable equal to 1 if the time is after the ACA policy intervention and equal to 0 if the 
time is before the ACA policy intervention, X is a vector of predisposing, enabling, and need 
variables. The coefficient β0 is the Y intercept, the utilization for the pre-intervention period, for 
the control group, when all control variables are equal to zero. The coefficient β1 is the time trend 
in the control group. It is equal to the difference in utilization among the uninsured (the control 
group) after the ACA provision. The coefficient β2 is the difference between the control and 
treatment groups pre- intervention. The coefficient of the interaction (POST*INSURED) is the 
coefficient of interest β3 which is the difference in differences term. It represents the difference of 
changes over time. β3 is the DID estimator that measures the effect of the policy intervention on 
insured individuals. Finally, the coefficient βn represents how Y changes when a single covariate 
changes holding other variables in the model constant. 
RESULTS 
Table 8 provides descriptive statistics of the predisposing, enabling, and need factors for 
the study sample before and after the implementation of the ACA cost-sharing elimination 
provision. For the total study sample, 228,777 eligible adults were identified, (77,381 before (2008 
to 2010) and 151,396 after (2011 to 2016)) ACA. The majority of the sample were adults who are 
less than 65 years old, non-Hispanic white, living in metropolitan area and insured. An independent 
two sample t-test “equal variances assumed” to compare the means for all model variables before 
and after the ACA was conducted. The results indicated that there is a statistically significant 
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difference between the means of most model variables. The mean age for the pre-ACA sample 
was 38.64 years, while the mean age for the post sample was 40.10 years (p<0.001). Females were 
51% of the sample both pre-and post ACA. The percent of married individuals was 44% pre and 
43% post ACA (p<0.001). Although statistically significant differences exist in the means of most 
demographic variables, the differences are likely attributable to the large sample size hence these 
differences are not meaningful. In general, there were changes in proportions in the different race 
groups. The percentage of Whites decreased significantly post ACA (72% to 70%, (p<0.001), 
while the percentage of Blacks increased (17% to 18% , p= 0.0158).  Hispanics were 24% of the 
sample pre and 27% post ACA (p<0.001). Education was significantly different on all levels, with 
a decrease for less than high school education from (31% to 29%, p<0.001) and for high school 
education from (27% to 24%, p<0.001), in contrast, there was an increase for some college 
education from (20% to 24%, p<0.001) and for four-year of college or more from (21% to 23%, 
p<0.001). For employment, 66% of the sample was employed for some part of the year. The mean 
income was $25,338 pre and $28,994 post ACA (p<0.001). Insured individuals represented 77% 
of the sample in the pre ACA period and 78% post ACA (p<0.001). Among all US regions, 20% 
of the sample lived in the Midwest pre and 19% post ACA (p<0.001). There was no statistical 
significance observed for other regions. For residence, 86% lived in a metropolitan area pre ACA 
and 88% post ACA (p<0.001). Of the participants, 66% thought they had excellent, very good 
health or good health pre-and post ACA, however, this was not statistically significant. Annually, 
a person visited their provider 4.10 visits during the pre ACA period and 4.38 visits post ACA 
(p<0.001). Of the participants, 12% smoked before the ACA, and 10% smoked after the ACA 
(p<0.001). The mean BMI of the sample was 27.71 pre-and 27.97 post ACA (p<0.001), indicating 
individuals are typically overweight. Table 8 shows the means and/or proportions of all model 
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variables with t-test results from comparison of their means. 
Table 8. Comparison of Means: T-test Results for Model Variables 
 Pre-ACA Post ACA  
        (n=77,381)      (n=151,396)    P-Value* 
Predisposing Factors 
 
Age-mean (SD) 
                   
                    
          38.64 (21.17)     
 
 
    40.10 (21.17) 
 
 
    <0.001 
 
Female- (%) 
 
0.51 
 
0.51 
 
0.54 
    
Race- (%) 
    White 
 
0.72 
 
0.70 
 
<0.001 
    Black 0.17 0.18 0.02 
    Native 0.01 0.01 <0.001 
    Asian 0.07 0.08 <0.001 
    Pacific Islander      0.00 0.00 <0.001 
    Multiple 0.02 0.03 <0.001 
    
Hispanic- (%) 0.24 0.27 <0.001 
    
Married (yes)- (%) 0.44 0.43 <0.001 
    
Education- (%) 
      Less Than HS 
 
0.31 
 
0.29 
 
<0.001 
     High School 0.27 0.24 <0.001 
     Some College 0.20 0.24 <0.001 
    4 years of college or + 0.21 0.23 <0.001 
    
Employed 0.66 0.66 0.13 
 
Enabling Factors 
 
Income-Mean                                        $25,338                   $28,994              <0.001 
             (SD) 
Insured- (%) 
 
Region- (%) 
      Northeast 
 ($31262) 
0.77 
 
 
            0.14 
       ($35526) 
           0.78 
 
 
0.14 
 
   <0.001 
 
 
0.46 
      Midwest 0.20            0.19 <0.001 
      South 0.38 0.39 0.004 
      West 0.27 0.27 0.48 
    
Metropolitan Area (yes)- (%) 0.86 0.88 <0.001 
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Regular Source of Care (yes)- 
(%) 
 
            0.74 
 
0.73 
 
0.1005 
    
No. of Annual Visits to 
Provider-mean (SD) 
4.10 (8.35) 4.38 (9.37) <0.001 
 
Need Factors 
 
Perceived Health Status-mean 
(SD) 
 
 
2.19 (0.90) 
 
 
2.19 (0.90) 
 
 
0.67 
    
No. of Chronic Conditions 1.02(1.53) 1.05(1.53) <0.001 
   
Smoker (yes)- (%) 0.12 0.10 <0.001 
    
BMI-mean (SD)  27.71(6.05)   27.97(6.26) <0.001 
    
Standard errors in parentheses 
+ p<.1, * p<.05, ** p<0.01, *** p<0.001  
*Two-sample t-test 
 
Results for Aim 1, Objective 1 
   Table 9 illustrates the number of women eligible and utilization proportions of 
mammography and pap smear before and after the ACA provision. An independent two sample t-
test “equal variances assumed” to compare utilization rates before and after the ACA was 
conducted. The results are irrespective of all other variables that were later included in the 
regression analysis. Of the 10,240 eligible women for mammography who participated in the 
MEPS survey pre-ACA (2008 to 2010), 72% were considered up-to-date. After the ACA (2011 to 
2016), 71% of the 21,967 eligible women were considered up-to-date on mammography, however, 
the reduction in mammography utilization was not statistically significant. For pap smear, 78% 
were considered up-to-date of the 25,114 eligible women pre ACA while 76% of the 49,679 
eligible women were considered up to date post ACA (p<0.001). Surprisingly, utilization of the 
pap smear test decreased significantly post ACA.  
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Table 9. Mammogram and Pap Smear Proportions Test 
 Pre-ACA Post ACA  
 Proportion 
(n) 
Recommended 
Proportion 
(n) 
Recommended 
    
    P-Value 
Mammogram 0.72 0.71 0.2422 
 (10240) (21967)  
Pap Smear  0.78 0.76 <0.001 
 (25114) (49679)  
    
 
Temporal trends of the proportion of individuals utilizing mammography and pap smear, 
among insured and uninsured women, pre-and post ACA were examined using the longitudinal 
data file. Figure 2 demonstrates the change in utilization proportion of women over time that are 
considered “up-to-date” on mammography based on recommended guidelines. However, Figure 2 
only illustrates the unadjusted rate of mammography use for both treatment and control groups 
over the period of the study. Rates of mammography have remained approximately the same 
during both periods for insured women, however, rates have slightly decrease post ACA among 
uninsured women. Figure 3 demonstrates the change in rates of pap smear use over time for insured 
and uninsured women. Rates of pap have slightly decreased post ACA among the both insured and 
uninsured women. The results illustrated in the trend figures 2 and 3 are surprisingly similar to the 
results from the Procedure Proportions Test in table 9. However, the effect that are detected in 
figures 2 and 3 could be biased by other factors that differentiate insured women from uninsured 
women, therefore, there is a need for adjusted analyses controlling for predisposing, enabling, and 
need factors that may impact the use of mammography and pap smear.  
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Figure 2. Rate of Mammography Use in Insured and Uninsured Women, 2008-2016 
 
Figure 3. Rate of Pap Smear Use in Insured and Uninsured Women, 2008-2016 
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Results for Aim 1, Objective 2 
To measure the receipt of mammography and pap smear, before and after the 
implementation of the ACA cost-sharing elimination provision, two logistic regressions were 
utilized. The models predict whether a woman received a mammography and/or pap smear based 
on the selected predisposing, enabling and need predictors. The results of the logistic regression 
models examining mammography and pap smear are presented in Tables 10 and 11, respectively. 
The tables include proportional odds ratios with the confidence intervals given the other model 
variables.  
There were 13,128 women who received a mammogram during the expected interval. 
Insured women were 82% more likely to receive a mammogram than uninsured women at any 
point during the study period (OR=1.82, 95% CI=1.56, 2.13, p=0.001). There was no change in 
mammography screening rates among uninsured women before and after the ACA provision.  
After the ACA, insured women were 10% more likely than uninsured women to receive a 
mammogram, however, this was not statistically significant.  
Predisposing Factors 
After controlling for all other variables. For each year older, women were 16% more likely 
to receive a mammogram (OR=1.16, 95% CI=1.03, 1.30, p<0.05). Hispanic women were 
approximately 66% more likely than non-Hispanic women to receive a mammogram (OR=1.66, 
95% CI=1.44, 1.91, p<0.001). For the variable race, black women were 53% more likely than 
white women to receive a mammogram (OR=1.53, 95% CI=1.35, 1.73, p<0.001), women from 
multiple races were 39% less likely than white women to get a mammogram (OR=0.605, 95% 
CI=0.43, 0.86, p<0.01); however, the results for all other races were not statistically significant. 
Married women were 34% more likely than non-married women to receive a mammogram 
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(OR=1.34, 95% CI=1.23, 1.47, p<0.001). For education, women with less than a high school 
education were 14% less likely than women with a high school education to get a mammogram 
(OR=0.86, 95% CI=0.76, 0.98, p<0.05). In addition, women with 4 years of college education or 
more were 26% more likely than women with a high school education to get a mammogram 
(OR=1.26, 95% CI=1.11, 1.42, p<0.001). The results for employment were not statistically 
significant. 
Enabling Factors 
 After controlling for all other variables, women who lived in the Midwest were 19% less 
likely than women who lived in the Northeast to get a mammogram (OR=0.81, 95% CI=0.69, 0.64, 
p<0.01); however, results were not statistically significant for other regions and residence in a 
metropolitan area. If a woman’s income was doubled, she was 12% more likely to get a 
mammogram (OR=1.12, 95% CI=1.08, 1.17, p<0.001). A woman with regular source of care was 
172% more likely to receive a mammogram (OR=2.72, 95% CI=2.41, 3.06, p<0.001). Each 
additional annual visit to a health provider results in a woman being 9% more likely to receive a 
mammogram (OR=1.09, 95% CI=1.08, 1.1, p<0.001).   
Need Factors 
Interestingly, one unit increase in perceived health status decreased the likelihood that a 
woman received a mammogram by 31% (OR=0.69, 95% CI=0.65, 0.73, p<0.001). Each additional 
chronic condition increased the likelihood of a woman receiving a mammogram by 40% 
(OR=1.40, 95% CI=1.31, 1.50, p<0.001). A woman who smoked was about 40% less likely to get 
a mammogram than a woman who did not smoke (OR=0.6, 95% CI=0.53, 0.68, p<0.001). Results 
were not statistically significant for BMI. 
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Table 10. Logistic Regression Results for Mammography  
    
                                         
Mammogram                  Odds Ratio  95% CI P-Value 
Independent Variables    
Post 
Insurance 
0.83 
1.82 
0.67,1.03 
1.56,2.13 
0.095+ 
0.000*** 
Insurance * Post 1.10 0.87,1.40 0.436 
Covariates: 
Predisposing Factors 
Age 
 
 
 
1.16 
 
 
 
1.03,1.30 
 
 
 
0.012* 
Age Squared 0.99 0.99,1.00 0.003** 
Race (white base) 
    Black 1.53 1.35,1.73 0.000*** 
    Native 0.67 0.43,1.06 0.088+ 
    Asian 0.84 0.71,1.01 0.066+ 
    Pacific Islander 0.87 0.43,1.76 0.7 
    Multiple 0.61 0.43,0.86 0.006** 
Hispanic 1.66 1.44,1.91 0.000*** 
Married 1.34 1.23,1.47 0.000*** 
Education (HS base) 
     Less Than HS 
 
0.86 
 
0.79,0.98 
 
0.027* 
     Some College          1.05 0.94,1.18 0.38 
     Four-Year College+          1.26 1.11,1.42 0.000*** 
Employed          0.92 0.81,1.04 0.159 
 
Enabling Factors 
Region (Northeast base) 
     Midwest 0.81 0.70,0.94 0.005** 
     South 0.96 0.84,1.09 0.54 
     West 0.94 0.81,1.09 0.41 
Metropolitan Area          0.94 0.83,1.06 0.28 
ln(Income)          1.12 1.08,1.17 0.000*** 
Regular Source of Care          2.72 2.41,3.06 0.000*** 
Visits          1.09 1.08,1.10 0.000*** 
Visits Squared          0.99 0.99,1.00 0.000*** 
 
Need Factors 
Perceived Health Status 
 
 
         0.69 
 
 
0.65,0.73 
 
 
0.000*** 
Chronic Conditions Count          1.40 1.31,1.50 0.000*** 
Chronic Conditions 
Squared 
0.96 0.95,0.97 0.000*** 
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Smoker          0.6 0.53,0.68 0.000*** 
BMI          0.99 0.99,1.00 0.32 
N 13,128   
AIC 12895.4   
Exponentiated coefficients; Standard errors in parentheses 
+ p<.1, * p<.05, ** p<0.01, *** p<0.001  
 
There were 30,945 women who received a pap smear during the expected interval. Women 
with insurance were 42% more likely to receive a pap smear than women without insurance at any 
point during the study period (OR=1.42, 95% CI=1.29, 1.56, p<0.001). There was no effect on 
pap smear among uninsured women before and after the ACA provision. After the ACA, insured 
women were 1% more likely to receive a pap smear, however, this was not statistically significant. 
Predisposing Factors 
After controlling for all other variables. For the linear term of age, each year older, women 
were 10% more likely to receive a pap smear (OR=1.1, 95% CI=1.08, 1.12, p<0.001). Hispanic 
women were 47% more likely than non-Hispanic women to receive a pap smear (OR=1.47, 95% 
CI=1.34, 1.59, p<0.001). For the variable race, Black women were 66% more likely than White 
women to receive a pap smear (OR=1.66, 95% CI=1.52, 1.82, p<0.001). Asian women were 45% 
less likely than White women to receive a pap smear (OR=0.55, 95% CI=0.49, 0.61, p<0.001), 
however, the results for all remaining races were not statistically significant. Married women were 
38% more likely than non-married women to receive a pap smear (OR=1.38, 95% CI=1.3, 1.5, 
p<0.001). For education, women with some college education were 24% more likely than women 
with high school education to get a pap smear (OR=1.24, 95% CI=1.14, 1.34, p<0.001). In 
addition, women with 4 years of college education or more were 49% more likely than women 
with a high school education to receive a pap smear (OR=1.49, 95% CI=1.36, 1.62, p<0.001). The 
impact of employment was not statistically significant.  
Enabling Factors 
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For enabling factors, region was not significant, however, women who lived in a 
metropolitan area were 22% more likely than women who did not live in a metropolitan area to 
receive a pap smear (OR=1.22, 95% CI=1.12, 1.34, p<0.001). In regards to income, when a 
woman’s income was doubled, she was 7% more likely to get a pap smear (OR=1.07, 95% 
CI=1.04, 1.09, p<0.001). A woman with regular source of care was 104% more likely to receive 
a pap smear (OR=2.04, 95% CI=1.9, 2.19, p<0.001). With one more visit to a health care provider 
per year, a woman was 7% more likely to receive a pap smear (OR=1.07, 95% CI=1.06, 1.08, 
p<0.001).  
Need Factors  
For one unit increase in perceived health status, a woman was 19% less likely to get a pap 
smear (OR=0.81, 95% CI=0.78, 0.85, p<0.001). With having one more chronic condition, a 
woman was 17% more likely to receive a pap smear (OR=1.17, 95% CI=1.11, 1.24, p<0.001). A 
woman who smoked was about 14% less likely to get a pap smear than a woman who did not 
smoke (OR=0.86, 95% CI=0.79, 0.93, p<0.001). For one unit increase in BMI, a woman was 1% 
less likely to receive a pap smear (OR=0.99, 95% CI=0.99, 1.00, p<0.05).  
 
Table 11. Logistic Regression Results for Pap smear  
    
Pap Smear Odds Ratio 95% CI P-Value 
    
Post 
Insurance 
0.94 
1.42 
0.84,1.05 
1.30,1.56 
0.28 
0.000*** 
Insurance * Post 1.01 0.88,1.16 0.88 
 
Predisposing Factors 
Age 
 
 
1.10 
 
 
1.08,1.12 
 
 
0.000*** 
Age Squared 
Race (White Base) 
0.99 0.99,0.99 0.000*** 
     Black 1.66 1.52,1.82 0.000*** 
     Native 1.28 0.92,1.78 0.15 
     Asian 0.55 0.49,0.61 0.000*** 
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     Pacific Islander 0.90 0.57,1.40 0.63 
     Multiple 0.83 0.65,1.07 0.15 
Hispanic 1.46 1.34,1.60 0.000*** 
Married 1.38 1.30,1.48 0.000*** 
Education (HS Base) 
     Less Than HS 
 
1.06 
 
0.96,1.17 
 
0.25 
     Some College 1.24 1.14,1.34 0.000*** 
     Four-Year College+ 1.49 1.36,1.62 0.000*** 
Employed 
 
Enabling Factors 
0.93 0.84,1.03 0.17 
Region (Northeast base) 
     Midwest 
     South 
     West 
 
          0.92 
          1.07 
          0.99 
 
0.83,1.02 
0.97,1.18 
0.90,1.10 
 
0.13 
0.18 
0.94 
Metropolitan Area 1.22 1.12,1.34 0.000*** 
ln(Income) 1.07 1.04,1.10 0.000*** 
Regular Source of Care 2.04 1.90,2.20 0.000*** 
Visits 1.07 1.06,1.08 0.000*** 
Visits Squared 0.99 0.99,1.00 0.000*** 
 
Need Factors 
Perceived Health Status 
 
 
0.81 
 
 
0.78,0.85 
 
 
0.000*** 
Chronic Conditions 
Count 
1.17 1.11,1.24 0.000*** 
Chronic Conditions 
Squared 
0.97 0.96,0.98 0.000*** 
Smoker 0.86 0.79,0.94 0.001*** 
BMI            0.99 0.98,0.99 0.012* 
N 30,945   
AIC 27593.46   
Exponentiated coefficients; Standard errors in parentheses 
+ p<.1, * p<.05, ** p<0.01, *** p<0.001  
 
 
Results for Aim 2, Objective 1 
Table 12 illustrates the number of individuals eligible and utilization proportions of FOBT, 
colonoscopy and sigmoidoscopy before and after the ACA provision. An independent two sample 
t-test “equal variances assumed” was performed to compare utilization rates before and after the 
ACA. The results are irrespective of all other variables that were later included in the regression 
analysis. Of the 20,183 eligible individuals for FOBT, 12% were considered up-to-date pre-ACA 
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and 11% of 43,497 post ACA. For colonoscopy, 50% were considered up-to-date of the 13,841 
eligible individuals pre-ACA while 54% of the 43,497 individuals were considered up-to-date post 
ACA. For sigmoidoscopy, 6% were considered up-to-date of the 13,841 eligible individuals pre-
ACA while 4% of the 43,497 individuals were considered up-to-date post ACA. The results were 
not statistically significant for FOBT, however, they were statistically significant for colonoscopy 
and sigmoidoscopy (p<0.001). Surprisingly, utilization of sigmoidoscopy decreased significantly 
post ACA and the utilization of colonoscopy was the only CRC cancer screening procedure that 
increased significantly post ACA.  
Table 12. FOBT, Colonoscopy and Sigmoidoscopy Proportions Test 
 Pre-ACA Post ACA  
 Proportion 
(n) 
Recommended 
Proportion 
(n) 
Recommended 
    
    P-Value 
    
Blood Stool  0.12 0.11 0.0730 
 (20,183) (43,497)  
Colonoscopy 0.50 0.54 <0.001 
 (13,841) (43,497)  
Sigmoidoscopy 0.06 0.04 <0.001 
  (13,841) (43,497)  
 
Figure 4, 5 and 6 illustrate the unadjusted utilization rate of FOBT, colonoscopy, and 
sigmoidoscopy for both treatment and control groups over the period of the study. Rates of FOBT 
have remained the same pre-ACA but suddenly decreased from 2011 to 2012 for both groups. 
Colonoscopy rates slightly increased for insured women compared to uninsured women post ACA. 
Sigmoidoscopy rates decreased similarly for both groups throughout the study period. The results 
illustrated in the figures 4,5 and 6 are surprisingly similar to the results from the Procedure 
Proportions Test in table 9. However, the effect that we detect in figures 4, 5 and 6 could be biased 
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by other factors that differentiate insured individuals from uninsured individuals, therefore, there 
was a need for adjusted analyses that controls for predisposing, enabling, and need factors that 
impact the use of CRC cancer screenings.  
Figure 4. Rate of FOBT Use in Insured and Uninsured Individuals, 2008-2016 
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Figure 5. Rate of Colonoscopy Use in Insured and Uninsured Individuals, 2008-2016 
 
Figure 6. Rate of Sigmoidoscopy Use in Insured and Uninsured Individuals, 2008-2016 
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Results for Aim 2, Objective 2 
To measure the receipt of FOBT before and after the implementation of the ACA cost-
sharing elimination provision, a logistic regression was utilized. The model predicts whether an 
individual received a FOBT based on the selected predisposing, enabling and need predictors. The 
results of logistic regression model are presented in Table 13. The table includes proportional odds 
ratios for the model with the confidence intervals for the odds ratios knowing the other predictors 
are in the model.  
In table 13, there were 26,728 individuals who were up-to-date on FOBT. There was no 
effect on FOBT among uninsured individuals before and after the ACA provision. Individuals with 
insurance were 47% more likely to get a FOBT than individuals without insurance at any point 
during the study period (OR=1.47, 95% CI=1.22, 1.78, p<0.001). After the ACA, insured 
individuals were approximately 4.3% more likely to get a FOBT, however, this was not statistically 
significant.  
Predisposing Factors 
After controlling for all other variables. For the linear term of age, each year older, 
individuals were 34% more likely to receive a FOBT (OR=1.34, 95% CI=1.2, 1.49, p<0.001). 
Women were 10% less likely than men to receive a FOBT (OR=0.90, 95% CI=0.83, 0.97, p<0.01). 
Hispanics were approximately 41% more likely than non-Hispanics to receive a FOBT (OR=1.41, 
95% CI=1.25, 1.6, p<0.001). For the variable race, Black individuals were 39% more likely than 
White individuals to receive a FOBT (OR=1.39, 95% CI=1.25, 1.55, p<0.001), however, the 
results for all other races were not statistically significant. For education, individuals with less than 
high school education were 14% less likely than individuals with high school education to receive 
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a FOBT (OR=0.86, 95% CI=0.75, 0.98, p<0.05). In addition, individuals with some college 
education (OR=1.21, 95% CI=1.09, 1.35, p<0.001) and individuals with 4 years of college 
education or more (OR=1.19, 95% CI=1.07, 1.32, p=0.001) were more likely than individuals with 
high school education to receive a FOBT. Employed people were 18% less likely than unemployed 
people to receive a FOBT (OR=0.82, 95% CI=0.74, 0.92, p<0.001).  
Enabling Factors 
For enabling factors, individuals who lived in the South (OR=1.24, 95% CI=1.1, 1.4, 
p=0.001) and individuals who lived in the West region (OR=1.90, 95% CI=1.68, 2.15, p=0.001) 
were more likely than individuals who lived in the Northeast to receive a FOBT. Individuals who 
lived in a metropolitan area were 27% more likely to receive a FOBT (OR=1.27, 95% CI=1.13, 
1.43, p=0.001). When an individual’s income was doubled, he/she was 7% more likely to receive 
a FOBT (OR=1.07, 95% CI=1.03, 1.11, p<0.01). A person with regular source of care was 137% 
more likely to receive a FOBT than a person without regular source of care (OR=2.37, 95% 
CI=2.01, 2.8, p<0.001). With one more visit to a health provider per year, a person was 3% more 
likely to receive a FOBT (OR=1.03, 95% CI=1.02, 1.04, p<0.001), in other words, the more office 
visits individuals had the more likely they received FOBT. 
Need Factors 
For one unit increase in perceived health status, a person was 5% less likely to receive a 
FOBT, however, this was not significant. With having one more chronic condition, a person was 
19% more likely to receive a FOBT (OR=1.19, 95% CI=1.12, 1.27, p<0.001). Results for smoking 
and BMI were not statistically significant.  
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Table 13. Logistic Regression Results for FOBT 
    
Blood Stool Odds Ratio  95% CI P-Value 
    
Post 
Insurance 
            0.83 
            1.47 
0.61,1.14 
1.22,1.78 
0.25 
0.000*** 
Insurance * Post        1.04 0.75,1.45 0.80 
 
Predisposing Factors 
Age 
 
 
       1.34 
 
 
1.19,1.49 
 
 
0.000*** 
Age Squared        0.99 0.99,0.99 0.000*** 
Female 
Race (White Base) 
       0.90 0.83,0.97 0.009** 
     Black 1.39 1.25,1.55 0.000*** 
     Native 1.29 0.84,1.97 0.24 
     Asian 1.14 0.97,1.34 0.12 
     Pacific Islander 1.19 0.68,2.07 0.54 
     Multiple 0.84 0.58,1.21 0.35 
Hispanic 1.41 1.25,1.60 0.000*** 
Married 1.08 0.99,1.18 0.075+ 
Education (HS Base) 
     Less Than HS 
 
0.86 
 
0.75,0.98 
 
0.027* 
     Some College 1.21 1.09,1.35 0.000*** 
     Four-Year 
College or+ 
1.19 1.07,1.32 0.001** 
Employed 
 
0.82 0.74,0.92 0.000*** 
Enabling Factors 
Region (Northeast 
base) 
     Midwest 
 
 
 
1.02 
 
 
 
0.89,1.18 
 
 
 
0.73 
     South 1.24 1.09,1.40 0.001*** 
     West 1.90 1.68,2.15 0.001*** 
Metropolitan Area 1.27 1.13,1.43 0.000*** 
ln(Income) 1.07 1.02,1.11 0.002** 
Regular Source of 
Care 
2.37 2.01,2.80 0.000*** 
Visits 1.03 1.02,1.04 0.000*** 
Visits Squared 1.00 1.00,1.00 0.000*** 
 
Need Factors 
Perceived Health 
Status 
 
 
0.95 
 
 
0.90,1.00 
 
 
0.051+ 
Chronic Conditions 
Count 
1.19 1.12,1.27 0.000*** 
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Chronic Conditions 
Squared 
0.99 0.98,0.99 0.002** 
Smoker 0.93 0.82,1.05 0.23 
BMI            0.99 0.99,1.00      0.42 
N 26,728   
AIC 18397.23   
Exponentiated coefficients; Standard errors in parentheses 
+ p<.1, * p<.05, ** p<0.01, *** p<0.001  
 
To measure the receipt of colonoscopy among individuals who were recommended to 
receive it, before and after the implementation of the ACA cost-sharing elimination provision, a 
logistic regression was utilized. The model predicts whether an individual received colonoscopy 
based on the selected predisposing, enabling and need predictors. The results of logistic regression 
model are presented in Table 14. The table includes proportional odds ratios for the model with 
the confidence intervals for the odds ratios knowing the other predictors are in the model.  
In table 14, there were 21,206 individuals who were up-to-date on colonoscopy. There was 
no effect on colonoscopy among uninsured individuals before and after the ACA provision. 
Individuals with insurance were 111% more likely to receive a colonoscopy than individuals 
without insurance at any point during the study period (2008 to 2016) (OR=2.11, 95% CI=1.83, 
2.42, p<0.001). After the ACA, insured individuals were approximately 5.1% more likely to get a 
colonoscopy, however, this was not statistically significant.  
Predisposing Factors 
After controlling for all other variables. For the linear term of age, each year older, 
individuals were 57% more likely to receive a colonoscopy (OR=1.57, 95% CI=1.44, 1.70, 
p<0.001). Women were 10% less likely than men to receive colonoscopy (OR=0.90, 95% 
CI=0.84, 0.95, p=0.001). Hispanics were approximately 21% less likely than non-Hispanics to 
receive colonoscopy (OR=0.79, 95% CI=0.72, 0.87, p<0.001). For the variable race, Blacks were 
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16% more likely than Whites to receive colonoscopy (OR=1.16, 95% CI=1.07, 1.27, p=0.001), 
whereas Asians (OR=0.58, 95% CI=0.51, 0.66, p<0.001) and pacific islanders (OR=0.51, 95% 
CI=0.32, 0.82, p<0.05) were less likely than whites to receive a colonoscopy. For education, 
individuals with less than high school education were 16% less likely than individuals with high 
school education to receive colonoscopy (OR=0.84, 95% CI=0.76, 0.93, p=0.001). In addition, 
individuals with some college education (OR=1.18, 95% CI=1.09, 1.28, p<0.001) and individuals 
with 4 years of college education or more (OR=1.45, 95% CI=1.34, 1.58, p<0.001) were more 
likely than individuals with high school education to receive colonoscopy. Employed people were 
21% less likely to get a colonoscopy than unemployed people (OR=0.79, 95% CI=0.73, 0.87, 
p<0.001). 
Enabling Factors 
For enabling factors, individuals who lived in the South (OR=0.90, 95% CI=0.82, 0.98, 
p<0.0) and the West (OR=0.73, 95% CI=0.67, 0.81, p<0.001) were less likely than individuals 
who lived in the Northeast to receive colonoscopy. Individuals who lived in a metropolitan area 
were 20% more likely to receive colonoscopy (OR=1.20, 95% CI=1.10, 1.31, p<0.001). When an 
individual’s income was doubled, he/she was 14% more likely to receive colonoscopy (OR=1.14, 
95% CI=1.10, 1.17, p<0.001). A person with regular source of care was 139% more likely to 
receive colonoscopy than a person without a regular source of care (OR=2.39, 95% CI=2.17, 2.63, 
p<0.001). With one more visit to a health provider per year, a person was 7% more likely to receive 
colonoscopy (OR=1.07, 95% CI=1.06, 1.07, p<0.001), in other words, the more office visits 
individuals had the more likely they received colonoscopy. 
Need Factors 
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For one unit increase in perceived health status, a person was 14% less likely to get a 
colonoscopy (OR=0.86, 95% CI=0.83, 0.9, p<0.001). With having one more chronic condition, a 
person was 33% more likely to receive colonoscopy (OR=1.33, 95% CI=1.26, 1.39, p<0.001). A 
smoker was 71% less likely to receive a colonoscopy than a non-smoker (OR=0.71, 95% CI=0.65, 
0.77, p<0.001). Results for BMI were not statistically significant.  
 
Table 14. Logistic Regression Results for Colonoscopy  
    
Colonoscopy              Odds Ratio 95% CI P-Value 
    
              
Post 
Insurance 
1.02 
2.11 
0.84,1.23 
1.83,2.42 
0.87 
0.000*** 
Insurance * Post 1.05 0.86,1.29 0.63 
 
Predisposing Factors 
Age 
 
 
1.57 
 
 
1.44,1.70 
 
 
0.000*** 
Age Squared 0.99 0.99,0.99 0.000*** 
Female 0.90 0.84,0.96 0.001*** 
Race (White base) 
     Black 
 
1.16 
 
1.07,1.27 
 
0.001*** 
     Native 0.73 0.51,1.03 0.076+ 
     Asian 0.58 0.51,0.66 0.000*** 
     Pacific Islander 0.51 0.32,0.82 0.005** 
     Multiple 0.94 0.72,1.24 0.67 
Hispanic 0.79 0.72,0.87 0.000*** 
Married 1.25 1.17,1.33 0.000*** 
Education (HS Base) 
     Less Than HS 
 
0.84 
 
0.76,0.93 
 
0.001*** 
     Some College 1.18 1.09,1.28 0.000*** 
     Four-Year College 
or + 
1.45 1.34,1.58 0.000*** 
Employed 0.79 0.73,0.87 0.000*** 
 
Enabling Factors 
Region (Northeast 
base) 
 
 
 
 
 
 
 
 
 
     Midwest 0.80 0.72,0.88 0.000*** 
     South 0.90 0.82,0.98 0.018* 
     West 0.73 0.67,0.81 0.000*** 
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Metropolitan Area 1.20 1.10,1.31 0.000*** 
ln(Income) 1.14 1.10,1.17 0.000*** 
Regular Source of Care 2.39 2.17,2.63 0.000*** 
Visits 1.07 1.06,1.07 0.000*** 
Visits Squared 0.99 0.99,1.00 0.000*** 
 
Need Factors 
Perceived Health Status 
 
 
0.86 
 
 
0.83,0.90 
 
 
0.000*** 
Chronic Conditions 
Count 
1.33 1.26,1.39 0.000*** 
Chronic Conditions 
Squared 
0.97 0.96,0.98 0.000*** 
Smoker 0.71 0.65,0.77 0.000*** 
BMI 1.00 0.99,1.01 0.90 
N 21,206      
AIC 24916.15   
Exponentiated coefficients; 
+ p<.1, * p<.05, ** p<0.01, *** p<0.001  
 
To measure the receipt of sigmoidoscopy before and after the implementation of the ACA 
cost-sharing elimination provision, a logistic regression was utilized. The model predicts whether 
an individual received sigmoidoscopy based on the selected predisposing, enabling and need 
predictors. The results of logistic regression model are presented in Table 15. The table includes 
proportional odds ratios for the model with the confidence intervals for the odds ratios knowing 
the other predictors are in the model.  
In table 15, there were 21,206 individuals who were up-to-date on sigmoidoscopy. There 
was no effect on sigmoidoscopy among uninsured individuals before and after the ACA provision. 
Individuals with insurance were 40% more likely to get sigmoidoscopy than individuals without 
insurance at any point during the study period (OR=1.40, 95% CI=1.04, 1.89, p<0.05). After the 
ACA, insured individuals were 6% less likely to receive sigmoidoscopy, however, this was not 
statistically significant. 
Predisposing Factors 
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 Holding all other variables constant, for the linear term of age, each year older, individuals 
were 51% more likely to receive a sigmoidoscopy (OR=1.51, 95% CI=1.27, 1.8, p<0.001). 
Women were 13% less likely than men to receive sigmoidoscopy (OR=0.87, 95% CI=0.76, 0.98, 
p<0.05). Hispanics were approximately 36% more likely than non-Hispanics to receive 
sigmoidoscopy (OR=1.36, 95% CI=1.13, 1.65, p=0.001). For the variable race, Black individuals 
were 23% more likely than Whites to receive sigmoidoscopy (OR=1.23, 95% CI=1.03, 1.47, 
p<0.05). The results for all other races were not significant. For education, individuals with some 
college education (OR=1.29, 95% CI=1.09, 1.52, p<0.01) and individuals with 4 years of college 
education (OR=1.27, 95% CI=1.07, 1.50, p<0.01) were more likely than individuals with high 
school education to receive sigmoidoscopy. Employed people were 10% less likely than 
unemployed people to get a sigmoidoscopy, however, this was not significant. 
Enabling Factors 
For enabling factors, individuals who lived in the West were 44% more likely than 
individuals who lived in the Northeast to receive sigmoidoscopy (OR=1.44, 95% CI=1.52, 2.23, 
p<0.001). Individuals who lived in a metropolitan area were 35% more likely to receive 
sigmoidoscopy (OR=1.35, 95% CI=1.11, 1.64, p<0.01). Results for income were not statistically 
significant. A person with regular source of care was 84% more likely to receive a sigmoidoscopy 
(OR=1.84, 95% CI=1.44, 2.34, p<0.001). With one more visit to a health care provider per year, 
a person was 2% more likely to receive a sigmoidoscopy (OR=1.02, 95% CI=1.01, 1.03, p<0.05), 
in other words, the more office visits individuals had the more likely they received sigmoidoscopy. 
Need Factors 
For one unit increase in perceived health status, a person was 5% more likely to get a 
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sigmoidoscopy, however, this was not significant. With having one more chronic condition, a 
person was 13% more likely to receive a sigmoidoscopy (OR=1.13, 95% CI=1.03, 1.24, p<0.05).  
Results for smoking and BMI were not statistically significant.  
Table 15. Logistic Regression Results for Sigmoidoscopy  
    
Sigmoidoscopy        Odds Ratio      95% CI                          P-Value 
    
Insurance 1.40 1.04,1.89 0.028* 
Post 0.77 0.49,1.20 0.24 
Insurance * Post 0.94 0.59,1.50 0.80 
 
Predisposing Factors 
Age 
 
 
1.51 
 
 
1.27,1.80 
 
 
0.000*** 
Age Squared 0.99 0.99,0.99 0.000*** 
Female 0.87 0.76,0.98 0.025* 
 Race (White Base) 
     Black 
 
1.23 
 
1.03,1.47 
 
0.020* 
     Native 1.08 0.54,2.15 0.82 
     Asian 1.05 0.82,1.34 0.72 
     Pacific Islander 0.30 0.07,1.24 0.096+ 
     Multiple 0.67 0.35,1.28 0.227 
Hispanic 1.36 1.13,1.65 0.001** 
Married 
Education (HS Base) 
0.93 0.82,1.07 0.30 
      Less Than HS 1.15 0.94,1.41 0.18 
      Some College 1.29 1.09,1.52 0.003** 
      Four-Year College or+ 1.27 1.07,1.50 0.007** 
Employed 
 
Enabling Factors 
Region (Northeast base) 
0.90 0.77,1.07 0.23 
     Midwest 0.91 0.74,1.14 0.42 
     South 0.98 0.81,1.19 0.86 
     West 1.84 1.52,2.23 0.000*** 
Metropolitan Area 1.35 1.11,1.64 0.002** 
ln(Income) 1.05 0.98,1.12 0.15 
Regular Source of Care 1.84 1.44,2.34 0.000*** 
Visits 1.02 1.01,1.03 0.004** 
Visits Squared 1.00 1.00,1.00 0.045* 
 
Need Factors 
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Perceived Health Status 1.05 0.97,1.14 0.22 
Chronic Conditions Count 1.13 1.03,1.24 0.013* 
Chronic Conditions 
Squared 
0.99 0.98,1.01 0.56 
Smoker 0.95 0.78,1.14 0.57 
BMI 1.00 0.99,1.01 0.99 
N 21,206   
AIC 8529.86   
Exponentiated coefficients; + p<.1, * p<.05, ** p<0.01, *** p<0.001  
+ p<.1, * p<.05, ** p<0.01, *** p<0.001  
 
 
 
DISCUSSION 
Our findings show that utilization rates post the ACA cost-sharing elimination provision 
did not increase for the examined cancer preventive services including mammography, pap smear, 
FOBT, colonoscopy and sigmoidoscopy. Given the decreased cost-sharing, it was expected that 
utilization will increase; however, there were some predisposing, enabling, and need factors that 
were associated with a change in utilization rates.  
The hypotheses for the study aims were that the utilization of cancer screenings will 
increase post the ACA cost-sharing elimination among privately and/or Medicare insured 
individuals as access to preventive care services increased under the ACA. The reasoning behind 
this hypothesis was that the elimination of all types of out-of-pocket would result in a greater 
probability of individuals obtaining cancer screenings; however, we did not detect statistically 
significant differences in utilization rates between insured and uninsured individuals in the DID 
estimation. Current findings agree with some previous studies that suggest lack of evidence of a 
positive gain from the ACA cost-sharing elimination provision. In 2015, three different studies 
evaluating the ACA provision found no significant change in utilization of breast, CRC and 
cervical cancer screenings among privately insured individuals (Mehta et al, 2015; Han et al, 2015; 
Jensen et al, 2015). Similarly, a recent study found that changes in the utilization of pap smear, 
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mammography, and CRC cancer screenings among the privately insured were not a result of the 
ACA (Hong et al, 2017). Prior studies with null findings blamed their results to several factors. 
First, many individuals involved in these studies held supplement insurance that covered a 
substantial amount or the full cost of cancer preventive services (Jensen et al, 2015). This applies 
to our study since the MEPS data does not contain additional information about supplemental 
coverage which could impact the results. Second, most of these studies did not have available data 
for long periods of time after the ACA. This was a problem because longer time is required to 
capture changes in utilization rates especially since all cancer screenings have screening intervals 
that are more than a year, however, this study contained data until 2016 which suggests enough 
time to observe changes in utilization. Third, cancer screening services are different than other 
screenings as they require more resources to be delivered including specialty equipment, 
professionals, and specific locations. In addition, from a patient’s perspective, cancer screening 
services would require time, geographic accessibility, obtainability of such specialty screenings, 
health education and cultural awareness (Han et al, 2015). Lastly, several states already had 
existing policies to reduce cost-sharing on preventive care services before the ACA (Kirby et al, 
2016). Therefore, there are other barriers that face cancer screenings that are not exclusively 
monetary in their types and are not related to cost-sharing.  
This study did not consider many psychosocial variables that influence health behavior 
including knowledge, attitudes, cultural beliefs, self-efficacy, and perceived threat. These are all 
important determinants of screening and even with the removal of cost barriers, they could still 
represent important barriers. A few studies have examined the relationship between cultural 
beliefs and patterns of cancer preventive care services utilization. For example, research has 
shown that cultural beliefs greatly influenced the perceptions of African-American women about 
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breast cancer and mammography. A study of African-American and white cancer patients found 
that the elderly, less educated, and African-American women were more likely to believe in 
nontraditional cancer treatments including salves (a healing ointment) and vitamins (Loehrer et 
al, 1991). Another study surveying African-American women showed that the respondents 
explained having cancer as a result of a biological process or the will of God (Gregg and Curry, 
1994). Finally, a study found that a substantial number of the African-American women were 
hesitant to obtain cancer treatment because of their fears about undesirable impacts on their 
relationships with their male partners, especially that they would not be physically attractive 
(Lannin et al, 1998). By evaluating various cultural barriers, cultural intervention strategies can 
be implemented to improve breast cancer screening utilization.  
Although current findings agree with prior research that showed no positive association of 
the cost-sharing elimination provision and the utilization of preventive care services, they differ 
from findings of several studies that showed significant increases in the utilization of preventive 
care services after the ACA. Lau and colleagues found a significant increase in the receipt of 
routine examination, blood pressure screening, cholesterol screening and the annual dental visit 
among young adults (Lau et al, 2014). Similarly, a study of a large community-based health system 
found that mammography usage increased significantly among women (Nelson et al, 2015). In 
addition, several studies showed a significant increase in mammography utilization among 
Medicare beneficiaries after the ACA (Cooper et al, 2016, Sabatino, et al, 2016; Jena et al, 2017). 
Those studies suggest positive gains from the ACA cost-sharing elimination provision; however, 
many examined a package of preventive services or found a slight increase in cancer screenings 
rates. This study examined only cancer preventive screenings and individuals who were eligible 
for these screenings who had private or Medicare coverage. 
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As mentioned earlier, there were some predisposing, enabling, and need factors that were 
associated with a change in utilization rates. The predisposing factors of age, education, and being 
Black increased the likelihood of receiving all cancer screenings, with being older and more 
educated, individuals had higher rates of cancer screenings after controlling for the other 
covariates. Being Hispanic increased the likelihood of receiving all cancer screenings except for 
colonoscopy. These findings disagree with prior research as it has shown that minorities, such as 
Hispanics and blacks were, in general, less likely than whites to receive preventive services such 
as cholesterol screening, blood pressure checks, and cancer screenings (Gornick, 2000). This might 
be attributed to having newer policies that increased the access to preventive care for minority 
groups. With respect to mammography and pap smear, married women were more likely receive 
them. Evaluation of CRC screenings showed that being employed or female decreased the 
likelihood of utilizing them. 
Enabling factors, such as having a regular source of care and more visits to a health care 
provider, increased the likelihood of receiving all cancer screenings. These findings agree with 
previous studies as many them found that receipt of preventive care services was strongly 
positively associated with having a constant source of care (DeVoe et al, 2003; Bednarek & 
Schone, 2003; Bandi et al, 2012; Allen et al, 2009). After controlling for other covariates, higher 
income individuals were more likely to receive all cancer screenings except for sigmoidoscopy. 
This was expected as previous studies have found that financial requirements tend to reduce the 
use of valuable care, especially for vulnerable groups such as low-income individuals (Chernew 
et al, 2007; Chandra et al, 2014). Similarly, living in a metropolitan area increased the likelihood 
to receive all cancer screenings except for mammography, after controlling for other covariates.  
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The need factors in this paper included perceived health status, number of chronic 
conditions, smoking status and BMI. After controlling for other covariates, having more than one 
chronic condition increased the likelihood of receiving all cancer screenings while having a 
lower perceived health status decreased the likelihood of receiving all cancer screenings except 
for sigmoidoscopy. Prior research has shown that the number of chronic diseases is correlated 
with increased cancer screenings. For example, hypertensive individuals had more breast exams, 
pap smears, FOBTs, and a trend to have more mammograms (Heflin et al, 2002). Also, women 
with three or more chronic conditions were shown to have more mammograms, pap smears, and 
breast exams (Yasmeen et al, 2011; Zao et al, 2008). In our study, smokers were less likely to 
receive mammography, pap smear, and colonoscopy.  Similarly, prior research has demonstrated 
that daily smokers were found to be less likely to receive cancer screening despite their increased 
risk of cancer (Vander et al, 2012). In regards to BMI, our study found that women with a higher 
BMI were less likely to receive a pap smear. This agrees with literature findings as studies have 
shown that that obese women were less likely to receive breast, cervical, or CRC cancer 
screening than normal weight women (Reidpath et al, 2002; Wee et al, 2002). 
This study had several limitations. The MEPS data contains self-reported answers to survey 
questions that are prone to recall error, however, since the error will have a similar effect 
throughout the different years, it will not significantly impact the outcomes of this study (Rauscher 
et al., 2008). In addition, the MEPS is cross-sectional panel data that only captures information at 
the point of the survey which might result in biased impact effects of some variables. Furthermore, 
the MEPS lacks data about supplemental coverage which might impact the results. Another 
limitation of this study is including uninsured individuals as a control group in the DID estimation. 
Uninsured individuals could be substantially different from insured individuals in utilization trends 
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of preventive care services before the implementation of the ACA provision. Those who are 
uninsured served as the control group because the implementation of the ACA provision did not 
affect them. The DID approach requires a control group that is very similar to the treatment group; 
however, there are some differences between the uninsured and insured individuals. The 
Uninsured are more likely to be low-income, Hispanic, and young (Kaiser Family Foundation, 
2013).
 
Nevertheless, since the implementation of the ACA has been a gradual system among all 
forms of insurance types, the uninsured were the single group that remained constant before and 
after the implementation of the ACA, which is the reason they were selected to serve as the control 
group.  
CONCLUSION 
Based on the findings of this study, the ACA cost-sharing elimination provision was not 
associated with an expected increase in utilization of preventive care services among Medicare 
and privately insured individuals. Despite the theories that out-of-pocket expenses are a barrier to 
preventative care utilization, the findings of this study and those of other researchers do not support 
them. Additional efforts might be necessary to complement the ACA cost-sharing elimination 
provision (Hong et al, 2017). These efforts would include enhancing the knowledge of people 
about the importance of preventive screenings in detecting cancer at an early stage, 
before symptoms appear, where treatment is easier and more successful to cure them and 
eventually save their lives. In addition, efforts in outreach and implementing educational 
campaigns to raise public awareness about the available health service benefits may increase 
awareness. In conclusion, the results of this study which supports the work of prior researchers 
suggest that future research is necessary to understand and evaluate the impact of cost-sharing on 
access to cancer preventive care services. 
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